<!DOCTYPE html>
<html class="no-js" lang="en">
<head>
  <meta charset="utf-8" />
  <meta http-equiv="x-ua-compatible" content="ie=edge" />
  <title>
    PharmCAT Report [hy]
  </title>

  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
  <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
  <!--[if lt IE 9]>
  <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
  <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
  <![endif]-->
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" />
  <style>
    html {
      font-size: 16px;
      background-color: #666666;
    }
    body {
      font-weight: 300;
      -moz-osx-font-smoothing: grayscale;
      -webkit-font-smoothing: antialiased;
      line-height: 1.5;
      font-size: 1rem;
      font-family: "Museo Sans W01 Rounded",Arial,Helvetica,sans-serif;
      color: rgb(25, 31, 42);
      background-color: #ffffff;
      margin: 0 auto;
      max-width: 70em;
      padding: 0;
    }
    header {
      margin-bottom: 1em;
    }
    main {
      margin: 1em 1em 0 1em;
      padding-bottom: 2em;
    }
    h1, h2, h3, h4 {
      margin-top: 0.5rem;
      margin-bottom: 0.5rem;
    }
    a, h1, h2, h3, h4, h5, h6 {
      color: #3e4c6c;
    }
    h1 {
      font-size: 2em;
      font-weight: 100;
    }
    h2, h3, h4 {
      font-weight: 300;
    }
    h2 {
      font-size: 1.8em;
    }
    h3 {
      font-size: 1.5em;
    }
    h4 {
      font-size: 1.2em;
    }
    p {
      margin-top: 0;
      margin-bottom: 1em;
    }
    section {
      margin-bottom: 2.5rem;
    }
    table, ul {
      margin-bottom: 1.5rem;
    }
    table {
      min-width: 100%;
      border-collapse: collapse;
      border-color: grey;
      font-size: 0.9rem;
    }
    td, th {
      border: 1px solid rgba(62, 76, 108, 0.1);
      max-width: 600px;
      word-wrap: break-word;
      padding: 1em 1.3em;
    }
    td p:last-child {
      margin-bottom: 0;
    }
    th {
      text-align: left;
    }
    tr.top-aligned td,th {
      vertical-align: top;
    }
    .table-small th {
      font-weight: normal;
      font-style: italic;
      width: 10em;
    }
    .table-small th, .table-small td {
      padding:.2em;
      font-size: .8em;
      border: 0;
    }
    table.diplotype {
      margin-bottom: 0;
    }
    table.genotypeSummary thead th {
      padding-bottom: 0;
    }
    table.diplotype td {
      width: 33%;
      padding: .2em .2em .2em 1em;
      border-width: 1px 0 0 0;
    }
    table.diplotype tbody tr:first-child td {
      border-top: 0;
    }
    tr.leastFunctionDiplotype td {
      color: #3f3f3f;
    }
    tr.leastFunctionDiplotype + tr td {
      border-top: 0;
    }
    table.diplotype tbody tr td:first-child {
      padding: .2em;
      border-left-width: 0;
    }
    table.diplotype tbody tr td {
      border-left-width: 1px;
    }


    .pageHeader {
      display: flex;
      align-items: center;
      padding: 1em 1em;
      background-color: #3e4c6c;
      color: #ffffff;
      min-width: 20em;
    }
    .pageHeader .title {
      font-weight: bold;
      font-size: 2em;
      min-width: 10em;
      width: 30%;
    }
    .pageHeader .subtitle {
      margin-left: .5em;
      font-size: .75em;
    }
    .pageHeader .metadata {
      min-width: 10em;
      width: 69%;
    }
    .pageHeader .metadata table {
      line-height: 1;
      margin: 0 .5em 0 auto;
      min-width: unset;
    }
    .pageHeader .metadata th {
      padding: 0 .5em 0 0;
      font-size: .8em;
      font-style: normal;
      font-weight: normal;
      text-align: right;
      vertical-align: top;
      white-space: nowrap;
    }
    .pageHeader .metadata td {
      font-size: .8em;
      padding: 0;
      vertical-align: top;
    }

    p.tdNote {
      margin-top: 1.2em;
      margin-bottom: 0;
      font-size: 0.9em;
    }
    p.tdNote + p.tdNote {
      margin-top: 1em;
      margin-bottom: 0;
      font-size: 0.9em;
    }

    hr {
      margin-bottom: 2em;
    }
    section.gene, section.guideline {
      margin-top: 2em;
      margin-bottom: 2em;
      border-bottom: 1px solid #DDD;
    }
    section.gene:last-child, section.guideline:last-child {
      border-bottom: 0;
    }

    ol.noPadding, ul.noPadding {
      padding-inline-start: 1rem;
    }
    ol.noBullet, ul.noBullet {
      list-style-type: none;
      padding-left: 0;
    }

    dl.compact dd {
      margin-left: 1em;
    }

    div.hint {
      text-transform: capitalize;
      font-size: .8em;
      color: #666666;
    }

    .alert {
      margin: 1em 0;
      padding: 0.6em;
      border-radius: 4px;
      text-shadow: 0 1px 0 rgba(255, 255, 255, 0.5);
      print-color-adjust: exact !important;
    }
    .alert-info {
      background-color: #d9edf7;
      border-color: #bce8f1;
      color: #3a87ad;
    }
    .alert-secondary {
      background-color: #f6f6f6;
      border-color: rgba(62, 76, 108, 0.1);
    }
    .alert-warning {
      background-color: #fcf8e3;
      border-color: #faebcc;
      color: #8a6d3b;
    }
    .alert-danger {
      background-color: #EAD6D5;
      border-color: #EFDFDE;
      color: #7C3A37;
    }
    .alert-danger h4 {
      color: #7C3A37;
      font-weight: bold;
    }
    .alert-debug {
      padding: 0.2em;
      background-color: #ffeeff;
    }

    .noGeneData {
      font-size: .8em;
      margin: 0 0.5em;
    }
    .drugName, .noWrap {
      white-space: nowrap;
    }
    .normalWrap {
      white-space: normal;
    }

    td.missingVariant {
      background-color: lightsalmon;
      print-color-adjust: exact !important;
    }

    td.mismatch {
      background-color: palegoldenrod;
      print-color-adjust: exact !important;
    }

    td.drugRecommendation ul {
      /* same as noPadding above */
      padding-inline-start: 1rem;
    }

    .mt-0 {
      margin-top: 0;
    }
    .mt-1 {
      margin-top: 0.5em;
    }
    .mb-0 {
      margin-bottom: 0;
    }
    .mb-1 {
      margin-bottom: 0.5em;
    }
    .mb-2 {
      margin-bottom: 1em;
    }

    div.callMessage {
      font-style: italic;
      font-weight: normal;
    }
    
    .geneCall {
      font-size: 1.2em;
    }

    .footnote {
      padding: .25em .5em;
      font-size: .8em;
    }
    .citations {
      font-size: .9em;
    }
    .footnote + .citations {
      margin-top: 1.5rem;
    }
    .sources {
      font-size: .8em;
    }
    .smallFont {
      font-size: .9em;
    }

    .footnote sup {
      font-style: normal;
    }

    #liability {
      font-size: 1.2em;
      color: darkred;
    }

    .warfarinFlowchart {
      text-align: center;
    }
    .warfarinFlowchart img {
      width: 100%;
      height: auto;
    }

    .nonwild {
      font-weight: bold;
    }

    .warningList {
      margin: 0;
      list-style: none;
      padding-left: 0;
    }

    sup a {
      text-decoration: none;
    }

    @media print {
      html {
        font-size: 12px;
      }

      body {
        width: 100%;
        max-width: none;
        margin: 0;
      }

      a {
        text-decoration: none;
      }

      img, pre, blockquote, table, figure, p {
        page-break-inside: avoid;
      }
    }
  </style>


</head>
<body>
<!--[if lt IE 9]>
<p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience.</p>
<![endif]-->
<header class="pageHeader">
  <div class="title">
    PharmCAT Report
    <div class="subtitle">hy</div>
  </div>
  <div class="metadata">
    <table>
      <tr><th>Date created</th><td>July 26, 2023</td></tr>
      <tr><th>PharmCAT Version</th><td>2.5.0</td></tr>
      <tr><th>CPIC Version</th><td>v1.26.0</td></tr>
    </table>
  </div>
</header>
<main>
  <section>
    <h2>Sections</h2>
    <ol type="I">
      <li><a href="#section-i">Genotype Summary</a></li>
      <li><a href="#section-ii">Prescribing Recommendations</a></li>
      <li><a href="#section-iii">Allele Matching Details</a></li>
      <li><a href="#disclaimer">Disclaimers</a></li>
    </ol>

    <div class="alert alert-info">
      <em>Disclaimer:</em> PharmCAT is only able to generate recommendations based on the information provided to the
      software. The gene and variant information for all reported sections are interpreted directly from user-supplied data.
      The user recognizes they are using PharmCAT at their own risk. For a full list of disclaimers and limitations see
      <a href="#disclaimer">Section IV</a>.
    </div>
  </section>


  <section id="section-i">
    <h2>Section I: Genotype Summary</h2>

    
    
      <p>Genotypes called: 19 / 23 </p>

      <table class="genotypeSummary">
        <thead>
        <tr>
          <th>Drugs</th>
          <th>Gene</th>
          <th>
            Genotypes
            <table class="diplotype table-small">
              <tbody>
              <tr>
                <td>Genotype</td>
                <td>Allele Functionality</td>
                <td>Phenotype</td>
              </tr>
              </tbody>
            </table>
          </th>
        </tr>
        </thead>
        <tbody>
        
          <tr class="top-aligned gs-ABCG2">
            <td>
              
                <div class="drugName">
                  
                    <a href="#allopurinol">allopurinol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rosuvastatin">rosuvastatin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#ABCG2" class="normalWrap">ABCG2</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs2231142 reference (G)/rs2231142 variant (T)</td>
                      <td>One Decreased function allele and one Normal function allele</td>
                      <td>Decreased Function</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CACNA1S">
            <td>
              
                <div class="drugName">
                  
                    <a href="#desflurane">desflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#enflurane">enflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#halothane">halothane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#isoflurane">isoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#methoxyflurane">methoxyflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sevoflurane">sevoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#succinylcholine">succinylcholine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CACNA1S" class="normalWrap">CACNA1S</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>No CPIC variants found</td>
                      <td>Two Normal function alleles</td>
                      <td>Uncertain Susceptibility</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CFTR">
            <td>
              
                <div class="drugName">
                  
                    <a href="#ivacaftor">ivacaftor</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CFTR" class="normalWrap">CFTR</a>
                
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>No CPIC variants found</td>
                      <td>Two ivacaftor non-responsive alleles</td>
                      <td>ivacaftor non-responsive in CF patients</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP2B6">
            <td>
              
                <div class="drugName">
                  
                    <a href="#efavirenz">efavirenz</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sertraline">sertraline</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP2B6" class="normalWrap">CYP2B6</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*9/*9</td>
                      <td>Two Decreased function alleles</td>
                      <td>Poor Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP2C19">
            <td>
              
                <div class="drugName">
                  
                    <a href="#amitriptyline">amitriptyline</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#citalopram">citalopram</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#clomipramine">clomipramine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#clopidogrel">clopidogrel</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#dexlansoprazole">dexlansoprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#doxepin">doxepin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#escitalopram">escitalopram</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#imipramine">imipramine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#lansoprazole">lansoprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#omeprazole">omeprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pantoprazole">pantoprazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sertraline">sertraline</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#trimipramine">trimipramine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#voriconazole">voriconazole</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP2C19" class="normalWrap">CYP2C19</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*38/*38</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP2C9">
            <td>
              
                <div class="drugName">
                  
                    <a href="#celecoxib">celecoxib</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#flurbiprofen">flurbiprofen</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fluvastatin">fluvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fosphenytoin">fosphenytoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#ibuprofen">ibuprofen</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#lornoxicam">lornoxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#meloxicam">meloxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#phenytoin">phenytoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#piroxicam">piroxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#siponimod">siponimod</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tenoxicam">tenoxicam</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#warfarin">warfarin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP2C9" class="normalWrap">CYP2C9</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*3/*3</td>
                      <td>Two No function alleles</td>
                      <td>Poor Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP3A4">
            <td>
              
                <div class="drugName">
                  
                    <a href="#quetiapine">quetiapine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP3A4" class="normalWrap">CYP3A4</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP3A5">
            <td>
              
                <div class="drugName">
                  
                    <a href="#tacrolimus">tacrolimus</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP3A5" class="normalWrap">CYP3A5</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*3/*3</td>
                      <td>Two No function alleles</td>
                      <td>Poor Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-CYP4F2">
            <td>
              
                <div class="drugName">
                  
                    <a href="#warfarin">warfarin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#CYP4F2" class="normalWrap">CYP4F2</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*4</td>
                      <td>N/A</td>
                      <td>N/A</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-DPYD">
            <td>
              
                <div class="drugName">
                  
                    <a href="#capecitabine">capecitabine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#flucytosine">flucytosine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fluorouracil">fluorouracil</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tegafur">tegafur</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#DPYD" class="normalWrap">DPYD</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  
                    <tr class="leastFunctionDiplotype gs-dip_leastFunction">
                      <td colspan="3"><b>c.1627A&gt;G (*5)/c.1627A&gt;G (*5)</b></td>
                    </tr>
                  
                  
                    <tr class="top-aligned gs-dip_component">
                      <td>c.1627A&gt;G (*5)</td>
                      <td>Normal function</td>
                      <td>See drug section</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-F5">
            <td>
              
                <div class="drugName">
                  
                    <a href="#hormonal_contraceptives_for_systemic_use">hormonal contraceptives for systemic use</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#F5" class="normalWrap">F5</a>
                
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs6025 C/rs6025 C</td>
                      <td>Two Factor V Leiden negative alleles</td>
                      <td>Factor V Leiden absent</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-G6PD">
            <td>
              
                <div class="drugName">
                  
                    <a href="#aminosalicylic_acid">aminosalicylic acid</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#aspirin">aspirin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#chloramphenicol">chloramphenicol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#chloroquine">chloroquine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#ciprofloxacin">ciprofloxacin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#dapsone">dapsone</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#dimercaprol">dimercaprol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#doxorubicin">doxorubicin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#furazolidone">furazolidone</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#glyburide">glyburide</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#hydroxychloroquine">hydroxychloroquine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#mafenide">mafenide</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#methylene_blue">methylene blue</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#nalidixic_acid">nalidixic acid</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#nitrofurantoin">nitrofurantoin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#norfloxacin">norfloxacin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#ofloxacin">ofloxacin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pegloticase">pegloticase</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#phenazopyridine">phenazopyridine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#primaquine">primaquine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#quinine">quinine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rasburicase">rasburicase</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sulfadiazine">sulfadiazine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sulfadimidine">sulfadimidine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sulfamethoxazole_trimethoprim">sulfamethoxazole / trimethoprim</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sulfanilamide">sulfanilamide</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sulfasalazine">sulfasalazine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sulfisoxazole">sulfisoxazole</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tafenoquine">tafenoquine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#tolbutamide">tolbutamide</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#toluidine_blue">toluidine blue</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#vitamin_c">vitamin c</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#vitamin_k">vitamin k</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#G6PD" class="normalWrap">G6PD</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>B (reference)/B (reference)</td>
                      <td>Two IV/Normal alleles</td>
                      <td>Normal</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-IFNL3/4">
            <td>
              
                <div class="drugName">
                  
                    <a href="#peginterferon_alfa_2a">peginterferon alfa-2a</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#peginterferon_alfa_2b">peginterferon alfa-2b</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#IFNL3/4" class="normalWrap">IFNL3/4</a>
                
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs12979860 reference (C)/rs12979860 reference (C)</td>
                      <td>N/A</td>
                      <td>N/A</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-NUDT15">
            <td>
              
                <div class="drugName">
                  
                    <a href="#azathioprine">azathioprine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#mercaptopurine">mercaptopurine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#thioguanine">thioguanine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#NUDT15" class="normalWrap">NUDT15</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-RYR1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#desflurane">desflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#enflurane">enflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#halothane">halothane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#isoflurane">isoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#methoxyflurane">methoxyflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#sevoflurane">sevoflurane</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#succinylcholine">succinylcholine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#RYR1" class="normalWrap">RYR1</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>No CPIC variants found</td>
                      <td>Two Normal function alleles</td>
                      <td>Uncertain Susceptibility</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-SLCO1B1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#atorvastatin">atorvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#fluvastatin">fluvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#lovastatin">lovastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pitavastatin">pitavastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#pravastatin">pravastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#rosuvastatin">rosuvastatin</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#simvastatin">simvastatin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#SLCO1B1" class="normalWrap">SLCO1B1</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*37/*37</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Function</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-TPMT">
            <td>
              
                <div class="drugName">
                  
                    <a href="#azathioprine">azathioprine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#mercaptopurine">mercaptopurine</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#thioguanine">thioguanine</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#TPMT" class="normalWrap">TPMT</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*1</td>
                      <td>Two Normal function alleles</td>
                      <td>Normal Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-UGT1A1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#atazanavir">atazanavir</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#irinotecan">irinotecan</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#UGT1A1" class="normalWrap">UGT1A1</a>
                <sup><a href="#genotypes-dagger">&dagger;</a></sup>
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>*1/*6</td>
                      <td>One Decreased function allele and one Normal function allele</td>
                      <td>Intermediate Metabolizer</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
          <tr class="top-aligned gs-VKORC1">
            <td>
              
                <div class="drugName">
                  
                    <a href="#acenocoumarol">acenocoumarol</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#phenprocoumon">phenprocoumon</a>
                  
                </div>
              
                <div class="drugName">
                  
                    <a href="#warfarin">warfarin</a>
                  
                </div>
              
            </td>
            <td>
              <span class="noWrap">
                <a href="#VKORC1" class="normalWrap">VKORC1</a>
                
                <sup><a href="#genotypes-ddagger">&ddagger;</a></sup>
              </span>
            </td>
            <td>
              <table class="diplotype">
                <tbody>
                
                  <!-- standard diplotype -->
                  
                    <tr class="top-aligned gs-dip">
                      <td>rs9923231 variant (T)/rs9923231 variant (T)</td>
                      <td>N/A</td>
                      <td>N/A</td>
                    </tr>
                  
                
                </tbody>
              </table>
              
              
            </td>
          </tr>
        
        </tbody>
      </table>

      

      
      
        <div class="footnote" id="genotypes-dagger">
          <sup>&dagger;</sup> Check <a href="#section-iii">Section III</a> for more details about this call.
        </div>
      
      
        <div class="footnote" id="genotypes-ddagger">
          <sup>&ddagger;</sup> PharmCAT reports the genotype(s) that receive the highest score during the matcher process.
          In case of unphased data, additional genotypes might be possible and cannot be ruled out.
        </div>
      
      <div class="footnote">
        For a full list of disclaimers and limitations see <a href="#disclaimer">Section IV</a>.
      </div>

      
      
    
  </section>


  <section id="section-ii">
    <h2>Section II: Prescribing Recommendations</h2>

    
      
        <section class="guideline abacavir">
          <h3 id="abacavir">abacavir</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-abacavir">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for HLA-B</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22378157" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22378157</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24561393" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24561393</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline acenocoumarol">
          <h3 id="acenocoumarol">acenocoumarol</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-acenocoumarol">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104938" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 variant (T)/<br />rs9923231 variant (T)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td>VKORC1: An INR ≥ 6, resulting in an increased risk of bleeding, occurs in 8-12% of these patients during the first weeks of treatment with standard regulation by the Anticoagulation Clinic. The genetic variation increases the sensitivity to acenocoumarol.</td>
                        <td class="drugRecommendation">Monitoring by the ANTICOAGULATION CLINIC (National INR Monitoring Service):
<ul>
<li>recommend to use 50% of the standard initial dose</li>
</ul>
OTHERWISE:
<ul>
<li>recommend to use 50% of the standard initial dose</li>
<li>recommend more frequent monitoring of the INR</li>
</ul></td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline allopurinol">
          <h3 id="allopurinol">allopurinol</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-allopurinol">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for HLA-B</span>.
                    
                  </td>
                </tr>
              
            
              
                
                  
                    <tr class="top-aligned dpwg-allopurinol">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166264961" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#ABCG2">ABCG2</a>:<br />rs2231142 reference (G)/<br />rs2231142 variant (T)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td>ABCG2: The effectiveness of allopurinol is reduced, meaning that a higher dose is required. The gene variation reduces the excretion of uric acid by kidneys and intestines, meaning that a stronger inhibition of the uric acid production by allopurinol is required to achieve the desired uric acid concentration.</td>
                        <td class="drugRecommendation">Use 1.25 times the standard dose.<br />
This equates to a dose titration schedule of 100, 200, 400 and 500 mg/day instead of the usual schedule of 100, 200, 300 and 400 mg/day.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23232549" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:23232549</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/26094938" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:26094938</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36056234" target="_blank" rel="noopener noreferrer">Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:36056234</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline amikacin">
          <h3 id="amikacin">amikacin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-amikacin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline aminosalicylic_acid">
          <h3 id="aminosalicylic_acid">aminosalicylic acid</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-aminosalicylic_acid">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline amitriptyline">
          <h3 id="amitriptyline">amitriptyline</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-amitriptyline">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>Normal Metabolizer</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>N/A</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Normal metabolism of tertiary amines</li><li>CYP2D6: N/A</li></ul></td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose.</td>
                        <td>Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-amitriptyline">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline aripiprazole">
          <h3 id="aripiprazole">aripiprazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-aripiprazole">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline aspirin">
          <h3 id="aspirin">aspirin</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-aspirin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />&lt;&#x3D; 1g per day</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td>aspirin ≤ 1 g/day</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline atazanavir">
          <h3 id="atazanavir">atazanavir</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-atazanavir">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#UGT1A1">UGT1A1</a>:*1/*6</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Intermediate Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>UGT1A1: Somewhat decreased UGT1A1 activity; low likelihood of bilirubin-related discontinuation of atazanavir.</td>
                        <td class="drugRecommendation">There is no need to avoid prescribing of atazanavir based on UGT1A1 genetic test result. Inform the patient that some patients stop atazanavir because of jaundice (yellow eyes and skin), but that this patient’s genotype makes this unlikely (less than about a 1 in 20 chance of stopping atazanavir because of jaundice).</td>
                        <td>All studies correlating UGT1A1 genotypes with atazanavir adverse events have involved ritonavir boosting. However, concentration-time profiles are equivalent when boosted with either cobicistat or ritonavir (PMID 23532097), and bilirubin-related adverse events including discontinuation of atazanavir occur in a similar percentage of patients prescribed atazanavir with cobicistat or ritonavir (PMID 23532097). Associations between UGT1A1 genotype, bilirubin elevations, and atazanavir/r discontinuation therefore almost certainly translate to atazanavir/cobicistat.</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/26417955" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing</a>. <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:26417955</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline atomoxetine">
          <h3 id="atomoxetine">atomoxetine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-atomoxetine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-atomoxetine">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30801677" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:30801677</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36509836" target="_blank" rel="noopener noreferrer">Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:36509836</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline atorvastatin">
          <h3 id="atorvastatin">atorvastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-atorvastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">Prescribe desired starting dose and adjust doses based on disease-specific guidelines.</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-atorvastatin">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182843" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline azathioprine">
          <h3 id="azathioprine">azathioprine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-azathioprine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>NUDT15:</dt><dd>Normal Metabolizer</dd><dt>TPMT:</dt><dd>Normal Metabolizer</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>NUDT15:</dt><dd>N/A</dd><dt>TPMT:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>NUDT15: Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression</li><li>TPMT: Lower concentrations of TGN metabolites, higher MeTIMP, this is the ‘normal’ pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.</li></ul></td>
                        <td class="drugRecommendation">Start with normal starting dose (e.g., 2-3 mg/kg/day) and adjust doses of azathioprine based on disease-specific guidelines. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11302950, 15606506).</td>
                        <td>Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-azathioprine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184614" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104934" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>NUDT15: The guideline does not provide a description of the impact of a normal metabolizer phenotype on azathioprine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for azathioprine in normal metabolizers</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-azathioprine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184614" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104934" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>TPMT: The guideline does not provide a description of the impact of a normal metabolizer phenotype on azathioprine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for azathioprine in normal metabolizers.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21270794" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21270794</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23422873" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23422873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30447069" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30447069</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline brexpiprazole">
          <h3 id="brexpiprazole">brexpiprazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-brexpiprazole">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
        </section>
      
        <section class="guideline capecitabine">
          <h3 id="capecitabine">capecitabine</h3>

          
            <div class="alert alert-info DPYD-lowest-activity-score-note">The two lowest activity values (variant activity scores, see CPIC guideline PMID: 29152729) are used for uphased data and the lowest activity value per allele are used for phased data to determine the gene activity score and phenotype to retrieve prescribing recommendations. </div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-capecitabine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:c.1627A>G (*5)/<br />c.1627A>G (*5)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>2.0</p>
                        
                      </td>
                    
                        <td>DPYD: Normal DPD activity and "normal" risk for fluoropyrimidine toxicity</td>
                        <td class="drugRecommendation">Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-capecitabine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104963" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:c.1627A>G (*5)/<br />c.1627A>G (*5)</span>
                                
                                <sup><a href="#rx-ddagger-capecitabine" title="Inferred">&ddagger;</a></sup>
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>2</p>
                        
                      </td>
                    
                        <td>DPYD: The guideline does not provide a description of the impact of a <em>DPYD</em> activity score of 2 on capecitabine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for capecitabine in patients with a <em>DPYD</em> activity score of 2.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
            <div class="footnote" id="rx-ddagger-capecitabine">
              <sup>&ddagger;</sup> The DPYD genotype used to look up phenotype is inferred from the two lowest function
              haplotypes. Consult the
              <a href="https://pharmcat.org/methods/Gene-Definition-Exceptions/#dpyd" target="_blank" rel="noopener noreferrer">PharmCAT documentation</a>
              for details.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23988873" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23988873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/29152729" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:29152729</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31745289" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.</a> <i>European journal of human genetics : EJHG</i>. 2019. PMID:31745289</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline carbamazepine">
          <h3 id="carbamazepine">carbamazepine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-carbamazepine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for HLA-A, HLA-B</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23695185" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23695185</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/29392710" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:29392710</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline celecoxib">
          <h3 id="celecoxib">celecoxib</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-celecoxib">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Initiate therapy with 25-50% of the lowest recommended starting dose. Titrate dose upward to clinical effect or 25-50% of the maximum recommended dose with caution. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. Upward dose titration should not occur until after steady state is reached (at least 8 days for celecoxib after first dose in PMs). Carefully monitor adverse events such as blood pressure and kidney function during course of therapy. Alternatively, consider an alternate therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo.</td>
                        <td>Alternative therapies not primarily metabolized by CYP2C9 include aspirin, ketorolac, naproxen and sulindac. Selection of therapy will depend on individual patient treatment goals and risks for toxicity.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline chloramphenicol">
          <h3 id="chloramphenicol">chloramphenicol</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-chloramphenicol">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline chloroquine">
          <h3 id="chloroquine">chloroquine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-chloroquine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ciprofloxacin">
          <h3 id="ciprofloxacin">ciprofloxacin</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-ciprofloxacin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline citalopram">
          <h3 id="citalopram">citalopram</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-citalopram">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ssri-and-snri-antidepressants/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2C19: Normal metabolism</td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-citalopram">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104977" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline clomipramine">
          <h3 id="clomipramine">clomipramine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-clomipramine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>Normal Metabolizer</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>N/A</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Normal metabolism of tertiary amines</li><li>CYP2D6: N/A</li></ul></td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose.</td>
                        <td>Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-clomipramine">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184528" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104964" target="_blank" rel="noopener noreferrer">2</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotypes</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-unmatched-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline clopidogrel">
          <h3 id="clopidogrel">clopidogrel</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-clopidogrel">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />CVI ACS PCI </p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity</td>
                        <td class="drugRecommendation">If considering clopidogrel, use at standard dose (75 mg/day)</td>
                        <td>For cardiovascular indications of acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI). ACS and/or PCI includes patients undergoing PCI for an ACS or non-ACS (elective) indication.</td>
                        <td>Strong</td>
                    
                  
                    <tr class="top-aligned cpic-clopidogrel">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />CVI non-ACS non-PCI</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity</td>
                        <td class="drugRecommendation">If considering clopidogrel, use at standard dose (75 mg/day)</td>
                        <td>For non-acute coronary syndrome (non-ACS) and non-percutaneous coronary intervention (non-PCI) cardiovascular indications. Non-ACS, non-PCI cardiovascular indications include peripheral arterial disease and stable coronary artery disease following a recent myocardial infarction outside the setting of PCI.</td>
                        <td>Strong</td>
                    
                  
                    <tr class="top-aligned cpic-clopidogrel">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />NVI</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity</td>
                        <td class="drugRecommendation">If considering clopidogrel, use at standard dose (75 mg/day)</td>
                        <td>For neurovascular indications. Neurovascular disease includes acute ischemic stroke or transient ischemic attack, secondary prevention of stroke, or prevention of thromboembolic events following neurointerventional procedures such as carotid artery stenting and stent-assisted coiling of intracranial aneurysms.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-clopidogrel">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104956" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21716271" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21716271</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23698643" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23698643</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35034351" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35034351</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline codeine">
          <h3 id="codeine">codeine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-codeine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-codeine">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22205192" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:22205192</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24458010" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24458010</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/33387367" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:33387367</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34267337" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34267337</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline dapsone">
          <h3 id="dapsone">dapsone</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-dapsone">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline desflurane">
          <h3 id="desflurane">desflurane</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-desflurane">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline desipramine">
          <h3 id="desipramine">desipramine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-desipramine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline dexlansoprazole">
          <h3 id="dexlansoprazole">dexlansoprazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-dexlansoprazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2C19: Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs</td>
                        <td class="drugRecommendation">Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.
Monitor for efficacy.</td>
                        <td>N/A</td>
                        <td>Optional</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32770672" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32770672</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline dibekacin">
          <h3 id="dibekacin">dibekacin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-dibekacin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline dimercaprol">
          <h3 id="dimercaprol">dimercaprol</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-dimercaprol">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline doxepin">
          <h3 id="doxepin">doxepin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-doxepin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>Normal Metabolizer</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>N/A</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Normal metabolism of tertiary amines</li><li>CYP2D6: N/A</li></ul></td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose.</td>
                        <td>Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-doxepin">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline doxorubicin">
          <h3 id="doxorubicin">doxorubicin</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-doxorubicin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline efavirenz">
          <h3 id="efavirenz">efavirenz</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-efavirenz">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />child &gt;40kg_adult</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2B6">CYP2B6</a>:*9/*9</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2B6: Higher dose-adjusted trough concentrations of efavirenz compared with normal metabolizers; significantly increased risk of CNS adverse events and treatment discontinuation</td>
                        <td class="drugRecommendation">Consider initiating efavirenz with decreased dose of 400 or 200 mg/day</td>
                        <td>If therapeutic drug monitoring is available and a decreased efavirenz dose is prescribed, consider obtaining steady-state plasma efavirenz concentrations to ensure concentrations are in the suggested therapeutic range (~1 to 4 μg/mL). To prescribe efavirenz at a decreased dose of 400 mg/day or 200 mg/day in a multidrug regimen may require prescribing more than one pill once daily. If so, the provider should weigh the potential benefit of reduced dose against the potential detrimental impact of increased pill number.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-efavirenz">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182846" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2B6">CYP2B6</a>:*9/*9</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31006110" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2019. PMID:31006110</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline eliglustat">
          <h3 id="eliglustat">eliglustat</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-eliglustat">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
        </section>
      
        <section class="guideline enflurane">
          <h3 id="enflurane">enflurane</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-enflurane">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline escitalopram">
          <h3 id="escitalopram">escitalopram</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-escitalopram">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ssri-and-snri-antidepressants/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2C19: Normal metabolism</td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-escitalopram">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104975" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline flecainide">
          <h3 id="flecainide">flecainide</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-flecainide">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline flucytosine">
          <h3 id="flucytosine">flucytosine</h3>

          
            <div class="alert alert-info DPYD-lowest-activity-score-note">The two lowest activity values (variant activity scores, see CPIC guideline PMID: 29152729) are used for uphased data and the lowest activity value per allele are used for phased data to determine the gene activity score and phenotype to retrieve prescribing recommendations. </div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-flucytosine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166222801" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:c.1627A>G (*5)/<br />c.1627A>G (*5)</span>
                                
                                <sup><a href="#rx-ddagger-flucytosine" title="Inferred">&ddagger;</a></sup>
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>2</p>
                        
                      </td>
                    
                        <td>DPYD: The guideline does not provide a description of the impact of a DPYD activity score of 2 on flucytosine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for flucytosine in patients with a DPYD activity score of 2.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
            <div class="footnote" id="rx-ddagger-flucytosine">
              <sup>&ddagger;</sup> The DPYD genotype used to look up phenotype is inferred from the two lowest function
              haplotypes. Consult the
              <a href="https://pharmcat.org/methods/Gene-Definition-Exceptions/#dpyd" target="_blank" rel="noopener noreferrer">PharmCAT documentation</a>
              for details.
            </div>
          

          

          
        </section>
      
        <section class="guideline fluorouracil">
          <h3 id="fluorouracil">fluorouracil</h3>

          
            <div class="alert alert-info DPYD-lowest-activity-score-note">The two lowest activity values (variant activity scores, see CPIC guideline PMID: 29152729) are used for uphased data and the lowest activity value per allele are used for phased data to determine the gene activity score and phenotype to retrieve prescribing recommendations. </div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-fluorouracil">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:c.1627A>G (*5)/<br />c.1627A>G (*5)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>2.0</p>
                        
                      </td>
                    
                        <td>DPYD: Normal DPD activity and "normal" risk for fluoropyrimidine toxicity</td>
                        <td class="drugRecommendation">Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-fluorouracil">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104939" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:c.1627A>G (*5)/<br />c.1627A>G (*5)</span>
                                
                                <sup><a href="#rx-ddagger-fluorouracil" title="Inferred">&ddagger;</a></sup>
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>2</p>
                        
                      </td>
                    
                        <td>DPYD: The guideline does not provide a description of the impact of a DPYD activity score of 2 on fluorouracil.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for fluorouracil in patients with a DPYD activity score of 2.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
            <div class="footnote" id="rx-ddagger-fluorouracil">
              <sup>&ddagger;</sup> The DPYD genotype used to look up phenotype is inferred from the two lowest function
              haplotypes. Consult the
              <a href="https://pharmcat.org/methods/Gene-Definition-Exceptions/#dpyd" target="_blank" rel="noopener noreferrer">PharmCAT documentation</a>
              for details.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23988873" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23988873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/29152729" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:29152729</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31745289" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.</a> <i>European journal of human genetics : EJHG</i>. 2019. PMID:31745289</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline flurbiprofen">
          <h3 id="flurbiprofen">flurbiprofen</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-flurbiprofen">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Initiate therapy with 25-50% of the lowest recommended starting dose. Titrate dose upward to clinical effect or 25-50% of the maximum recommended dose with caution. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. Upward dose titration should not occur until after steady state is reached (at least 8 days for celecoxib after first dose in PMs). Carefully monitor adverse events such as blood pressure and kidney function during course of therapy. Alternatively, consider an alternate therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo.</td>
                        <td>Alternative therapies not primarily metabolized by CYP2C9 include aspirin, ketorolac, naproxen and sulindac. Selection of therapy will depend on individual patient treatment goals and risks for toxicity.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline fluvastatin">
          <h3 id="fluvastatin">fluvastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-fluvastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>;<br /><span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2C9:</dt><dd>Poor Metabolizer</dd><dt>SLCO1B1:</dt><dd>Normal Function</dd></dl>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C9: Increased fluvastatin exposure as compared to normal and intermediate metabolizer which may translate to increased myopathy risk.</li><li>SLCO1B1: Typical myopathy risk and statin exposure.</li></ul></td>
                        <td class="drugRecommendation">Prescribe ≤20mg per day as a starting dose and adjust doses of fluvastatin based on disease-specific guidelines. If dose >20mg needed for desired efficacy, consider an alternative statin or combination therapy (i.e., fluvastatin plus non-statin guideline directed medical therapy) (PMID: 30423391).</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function should be evaluated prior to initiating a statin. The effects of drug-drug interactions may be more pronounced resulting in a higher risk of myopathy.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline fluvoxamine">
          <h3 id="fluvoxamine">fluvoxamine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-fluvoxamine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline fosphenytoin">
          <h3 id="fosphenytoin">fosphenytoin</h3>

          
            <div class="alert alert-info Phenytoin-HLA-B-warning">The displayed recommendation for CYP2C9 and phenytoin is ONLY valid for non-carriers of the HLA-B*15:02 high-risk allele. PharmCAT Named Allele Matcher does not determine HLA status. CPIC guidance: Fos-/Phenytoin is contraindicated in individuals with the HLA-B*15:02 variant allele ("HLA-B*15:02-positive") due to significantly increased risk of fos-/phenytoin-induced cutaneous adverse reactions of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). In HLA-B*15:02 carriers, carbamazepine should not be used as an alternative. Alternative medications such as oxcarbazepine, eslicarbazepine acetate, and lamotrigine have some evidence linking SJS/TEN with the HLA-B*15:02 allele, and thus caution should be used in choosing alternatives to phenytoin.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-fosphenytoin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                        <sup class="sources">
                          <a href="https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotypes</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>;<br /><span class="rx-unmatched-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/25099164" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:25099164</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32779747" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32779747</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline furazolidone">
          <h3 id="furazolidone">furazolidone</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-furazolidone">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline gentamicin">
          <h3 id="gentamicin">gentamicin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-gentamicin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline glyburide">
          <h3 id="glyburide">glyburide</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-glyburide">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline haloperidol">
          <h3 id="haloperidol">haloperidol</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-haloperidol">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline halothane">
          <h3 id="halothane">halothane</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-halothane">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline hormonal_contraceptives_for_systemic_use">
          <h3 id="hormonal_contraceptives_for_systemic_use">hormonal contraceptives for systemic use</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-hormonal_contraceptives_for_systemic_use">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104955" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#F5">F5</a>:rs6025 C/<br />rs6025 C</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td>F5: The guideline does not provide a description of the impact of the absence of Factor V Leiden on estrogen-containing contraceptives.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for estrogen-containing contraceptives in patients who do not have the Factor V Leiden variant.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline hydrocodone">
          <h3 id="hydrocodone">hydrocodone</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-hydrocodone">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22205192" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:22205192</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24458010" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24458010</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/33387367" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:33387367</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline hydroxychloroquine">
          <h3 id="hydroxychloroquine">hydroxychloroquine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-hydroxychloroquine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ibuprofen">
          <h3 id="ibuprofen">ibuprofen</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-ibuprofen">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Initiate therapy with 25-50% of the lowest recommended starting dose. Titrate dose upward to clinical effect or 25-50% of the maximum recommended dose with caution. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. Upward dose titration should not occur until after steady state is reached (at least 8 days for celecoxib after first dose in PMs). Carefully monitor adverse events such as blood pressure and kidney function during course of therapy. Alternatively, consider an alternate therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo.</td>
                        <td>Alternative therapies not primarily metabolized by CYP2C9 include aspirin, ketorolac, naproxen and sulindac. Selection of therapy will depend on individual patient treatment goals and risks for toxicity.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline imipramine">
          <h3 id="imipramine">imipramine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-imipramine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>Normal Metabolizer</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>N/A</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Normal metabolism of tertiary amines</li><li>CYP2D6: N/A</li></ul></td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose.</td>
                        <td>Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-imipramine">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104954" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104972" target="_blank" rel="noopener noreferrer">2</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotypes</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-unmatched-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline irinotecan">
          <h3 id="irinotecan">irinotecan</h3>

          
            <div class="alert alert-info irinotecan-DPWG">Alleles determined based on the CPIC UGT1A1 allele definition file due to limited allele definition information in the DPWG UGT1A1 document</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-irinotecan">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104951" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#UGT1A1">UGT1A1</a>:*1/*6</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Intermediate Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>UGT1A1: This genetic variation (IM) is more common in Western populations than the wild-type (*1/*1). This means that treatment is largely geared to patients with this genetic variation. Adjustment of the treatment is therefore not useful.</td>
                        <td class="drugRecommendation">NO action is needed for this gene-drug interaction.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36443464" target="_blank" rel="noopener noreferrer">Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:36443464</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline isoflurane">
          <h3 id="isoflurane">isoflurane</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-isoflurane">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ivacaftor">
          <h3 id="ivacaftor">ivacaftor</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-ivacaftor">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CFTR">CFTR</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>ivacaftor non-responsive in CF patients</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CFTR: An individual diagnosed with cystic fibrosis (CF) and negative for a CFTR variant listed in the FDA-approved drug label as being responsive to ivacaftor.</td>
                        <td class="drugRecommendation">Ivacaftor is not recommended</td>
                        <td>N/A</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24598717" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24598717</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline kanamycin">
          <h3 id="kanamycin">kanamycin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-kanamycin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline lansoprazole">
          <h3 id="lansoprazole">lansoprazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-lansoprazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2C19: Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs</td>
                        <td class="drugRecommendation">Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.
Monitor for efficacy.</td>
                        <td>N/A</td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-lansoprazole">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104987" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32770672" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32770672</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline lornoxicam">
          <h3 id="lornoxicam">lornoxicam</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-lornoxicam">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Initiate therapy with 25-50% of the lowest recommended starting dose. Titrate dose upward to clinical effect or 25-50% of the maximum recommended dose with caution. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. Upward dose titration should not occur until after steady state is reached (at least 8 days for celecoxib after first dose in PMs). Carefully monitor adverse events such as blood pressure and kidney function during course of therapy. Alternatively, consider an alternate therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo.</td>
                        <td>Alternative therapies not primarily metabolized by CYP2C9 include aspirin, ketorolac, naproxen and sulindac. Selection of therapy will depend on individual patient treatment goals and risks for toxicity.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline lovastatin">
          <h3 id="lovastatin">lovastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-lovastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">Prescribe desired starting dose and adjust doses based on disease-specific guidelines.</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline mafenide">
          <h3 id="mafenide">mafenide</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-mafenide">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline meloxicam">
          <h3 id="meloxicam">meloxicam</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-meloxicam">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Choose an alternative therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo or choose an NSAID metabolized by CYP2C9 but with a shorter half-life (see CPIC THERAPEUTIC RECOMMENDATIONS FOR CELECOXIB, FLURBIPROFEN, LORNOXICAM, AND IBUPROFEN BASED ON CYP2C9 PHENOTYPE).</td>
                        <td>N/A</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline mercaptopurine">
          <h3 id="mercaptopurine">mercaptopurine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-mercaptopurine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>NUDT15:</dt><dd>Normal Metabolizer</dd><dt>TPMT:</dt><dd>Normal Metabolizer</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>NUDT15:</dt><dd>N/A</dd><dt>TPMT:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>NUDT15: Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression</li><li>TPMT: Lower concentrations of TGN metabolites, higher MeTIMP, this is the ‘normal’ pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.</li></ul></td>
                        <td class="drugRecommendation">Start with normal starting dose (e.g., 75 mg/m2/day or 1.5 mg/kg/day) and adjust doses of mercaptopurine (and of any other myelosuppressive therapy) without any special emphasis on mercaptopurine compared to other agents. Allow at least 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 16401827, 11302950).</td>
                        <td>Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-mercaptopurine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184613" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104952" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>NUDT15: The guideline does not provide a description of the impact of a normal metabolizer phenotype on mercaptopurine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for mercaptopurine in normal metabolizers</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-mercaptopurine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184613" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104952" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>TPMT: The guideline does not provide a description of the impact of a normal metabolizer phenotype on mercaptopurine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for mercaptopurine in normal metabolizers.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21270794" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21270794</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23422873" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23422873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30447069" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30447069</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline methoxyflurane">
          <h3 id="methoxyflurane">methoxyflurane</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-methoxyflurane">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline methylene_blue">
          <h3 id="methylene_blue">methylene blue</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-methylene_blue">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid ased on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline metoprolol">
          <h3 id="metoprolol">metoprolol</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-metoprolol">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline nalidixic_acid">
          <h3 id="nalidixic_acid">nalidixic acid</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-nalidixic_acid">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline neomycin">
          <h3 id="neomycin">neomycin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-neomycin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline netilmicin">
          <h3 id="netilmicin">netilmicin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-netilmicin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline nitrofurantoin">
          <h3 id="nitrofurantoin">nitrofurantoin</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-nitrofurantoin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline norfloxacin">
          <h3 id="norfloxacin">norfloxacin</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-norfloxacin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline nortriptyline">
          <h3 id="nortriptyline">nortriptyline</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-nortriptyline">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-nortriptyline">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ofloxacin">
          <h3 id="ofloxacin">ofloxacin</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-ofloxacin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline omeprazole">
          <h3 id="omeprazole">omeprazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-omeprazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2C19: Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs</td>
                        <td class="drugRecommendation">Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.
Monitor for efficacy.</td>
                        <td>N/A</td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-omeprazole">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104957" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32770672" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32770672</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ondansetron">
          <h3 id="ondansetron">ondansetron</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-ondansetron">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/28002639" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:28002639</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline oxcarbazepine">
          <h3 id="oxcarbazepine">oxcarbazepine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-oxcarbazepine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for HLA-B</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23695185" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23695185</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/29392710" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:29392710</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pantoprazole">
          <h3 id="pantoprazole">pantoprazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-pantoprazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP2C19: Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs</td>
                        <td class="drugRecommendation">Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.
Monitor for efficacy.</td>
                        <td>N/A</td>
                        <td>Moderate</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-pantoprazole">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104958" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32770672" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32770672</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline paromomycin">
          <h3 id="paromomycin">paromomycin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-paromomycin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline paroxetine">
          <h3 id="paroxetine">paroxetine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-paroxetine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-paroxetine">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline peginterferon_alfa_2a">
          <h3 id="peginterferon_alfa_2a">peginterferon alfa-2a</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-peginterferon_alfa_2a">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                        <sup class="sources">
                          <a href="https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#IFNL3">IFNL3</a>:rs12979860 reference (C)/rs12979860 reference (C)</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24096968" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:24096968</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline peginterferon_alfa_2b">
          <h3 id="peginterferon_alfa_2b">peginterferon alfa-2b</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-peginterferon_alfa_2b">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                        <sup class="sources">
                          <a href="https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#IFNL3">IFNL3</a>:rs12979860 reference (C)/rs12979860 reference (C)</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24096968" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:24096968</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pegloticase">
          <h3 id="pegloticase">pegloticase</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-pegloticase">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline phenazopyridine">
          <h3 id="phenazopyridine">phenazopyridine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-phenazopyridine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline phenprocoumon">
          <h3 id="phenprocoumon">phenprocoumon</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-phenprocoumon">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104940" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 variant (T)/<br />rs9923231 variant (T)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td>VKORC1: An INR ≥ 6, resulting in an increased risk of bleeding, occurs in 17% of these patients with standard regulation by the Anticoagulation Clinic. The genetic variation increases the sensitivity to phenprocoumon.</td>
                        <td class="drugRecommendation">Monitoring by a ANTICOAGULATION CLINIC:
<ul>
<li>recommend to use 50% of the standard initial dose</li>
</ul>
NO monitoring by a anticoagulation clinic:
<ul>
<li>recommend to use 50% of the standard initial dose</li>
<li>recommend more frequent monitoring of the INR</li>
</ul></td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline phenytoin">
          <h3 id="phenytoin">phenytoin</h3>

          
            <div class="alert alert-info Phenytoin-HLA-B-warning">The displayed recommendation for CYP2C9 and phenytoin is ONLY valid for non-carriers of the HLA-B*15:02 high-risk allele. PharmCAT Named Allele Matcher does not determine HLA status. CPIC guidance: Fos-/Phenytoin is contraindicated in individuals with the HLA-B*15:02 variant allele ("HLA-B*15:02-positive") due to significantly increased risk of fos-/phenytoin-induced cutaneous adverse reactions of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). In HLA-B*15:02 carriers, carbamazepine should not be used as an alternative. Alternative medications such as oxcarbazepine, eslicarbazepine acetate, and lamotrigine have some evidence linking SJS/TEN with the HLA-B*15:02 allele, and thus caution should be used in choosing alternatives to phenytoin.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-phenytoin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                        <sup class="sources">
                          <a href="https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotypes</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>;<br /><span class="rx-unmatched-dip"><a href="#HLA-B">HLA-B</a>:Unknown/Unknown</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
              
                
                  
                    <tr class="top-aligned dpwg-phenytoin">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104984" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C9: Genetic variation reduces conversion of phenytoin to inactive metabolites. This increases the risk of side effects. The life-threatening cutaneous side effects Stevens-Johnson Syndrome and toxic epidermal necrolysis may occur, especially in Asian patients.</td>
                        <td class="drugRecommendation"><ol>
<li>The loading dose does not need to be adjusted.</li>
<li>For the other doses, use 40% of the standard dose and assess the dose based on effect and serum concentration after 7-10 days.</li>
<li>Advise the patient to get in touch if side effects (such as ataxia, nystagmus, slurred speech, sedation or, especially in Asian patients, rash) occur.</li>
</ol></td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/25099164" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:25099164</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32779747" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32779747</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pimozide">
          <h3 id="pimozide">pimozide</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-pimozide">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
        </section>
      
        <section class="guideline piroxicam">
          <h3 id="piroxicam">piroxicam</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-piroxicam">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Choose an alternative therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo or choose an NSAID metabolized by CYP2C9 but with a shorter half-life (see CPIC THERAPEUTIC RECOMMENDATIONS FOR CELECOXIB, FLURBIPROFEN, LORNOXICAM, AND IBUPROFEN BASED ON CYP2C9 PHENOTYPE).</td>
                        <td>Alternative therapies not primarily metabolized by CYP2C9 include aspirin, ketorolac, naproxen and sulindac. Selection of therapy will depend on individual patient treatment goals and risks for toxicity.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pitavastatin">
          <h3 id="pitavastatin">pitavastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-pitavastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">Prescribe desired starting dose and adjust doses based on disease-specific guidelines.</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline plazomicin">
          <h3 id="plazomicin">plazomicin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-plazomicin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline pravastatin">
          <h3 id="pravastatin">pravastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-pravastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">Prescribe desired starting dose and adjust doses based on disease-specific guidelines.</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline primaquine">
          <h3 id="primaquine">primaquine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-primaquine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline propafenone">
          <h3 id="propafenone">propafenone</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-propafenone">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline quetiapine">
          <h3 id="quetiapine">quetiapine</h3>

          
            <div class="alert alert-info CYP3A4">The CYP3A4 alleles are determined based on PharmVar CYP3A4 allele definitions. See PharmCAT disclaimer for further information.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-quetiapine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166265421" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A4">CYP3A4</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP3A4: The guideline does not provide a description of the impact of a normal metabolizer phenotype on quetiapine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for quetiapine in normal metabolizers.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
        </section>
      
        <section class="guideline quinine">
          <h3 id="quinine">quinine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-quinine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline rasburicase">
          <h3 id="rasburicase">rasburicase</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-rasburicase">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline ribostamycin">
          <h3 id="ribostamycin">ribostamycin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-ribostamycin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline risperidone">
          <h3 id="risperidone">risperidone</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-risperidone">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline rosuvastatin">
          <h3 id="rosuvastatin">rosuvastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-rosuvastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#ABCG2">ABCG2</a>:<br />rs2231142 reference (G)/<br />rs2231142 variant (T)</span>;<br /><span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>ABCG2:</dt><dd>Decreased Function</dd><dt>SLCO1B1:</dt><dd>Normal Function</dd></dl>
                        
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>ABCG2: Increased rosuvastatin exposure as compared to normal function; unknown risk for myopathy; increased lipid lowering effects</li><li>SLCO1B1: Typical myopathy risk and statin exposure</li></ul></td>
                        <td class="drugRecommendation">Prescribe desired starting dose and adjust doses of rosuvastatin based on disease-specific and specific population guidelines.</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function and Asian ancestry should be evaluated prior to initiating rosuvastatin. The effects of drug-drug interactions may be more pronounced resulting in a higher risk of myopathy.</td>
                        <td>Moderate</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sertraline">
          <h3 id="sertraline">sertraline</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sertraline">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ssri-and-snri-antidepressants/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2B6">CYP2B6</a>:*9/*9</span>;<br /><span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2B6:</dt><dd>Poor Metabolizer</dd><dt>CYP2C19:</dt><dd>Normal Metabolizer</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CYP2B6:</dt><dd>N/A</dd><dt>CYP2C19:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2B6: Greatly reduced metabolism of sertraline to less active compounds when compared to CYP2B6 normal metabolizers. Higher plasma concentrations may increase the probability of side effects.</li><li>CYP2C19: Normal metabolism</li></ul></td>
                        <td class="drugRecommendation">Consider a lower starting dose, slower titration schedule and 25% reduction of standard maintenance dose as compared to CYP2B6 normal metabolizers or select a clinically appropriate alternative antidepressant not predominantly metabolized by CYP2B6.</td>
                        <td>N/A</td>
                        <td>Optional</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-sertraline">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104980" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34782755" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34782755</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sevoflurane">
          <h3 id="sevoflurane">sevoflurane</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sevoflurane">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline simvastatin">
          <h3 id="simvastatin">simvastatin</h3>

          
            <div class="alert alert-info SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-simvastatin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-statins/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Function</p>
                        
                        
                      </td>
                    
                        <td>SLCO1B1: Typical myopathy risk and statin exposure</td>
                        <td class="drugRecommendation">Prescribe desired starting dose and adjust doses based on disease-specific guidelines.</td>
                        <td>The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-simvastatin">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182844" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#SLCO1B1">SLCO1B1</a>:*37/*37</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22617227" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy</a>. <i>Clinical pharmacology and therapeutics</i>. 2012. PMID:22617227</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24918167" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24918167</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/35152405" target="_blank" rel="noopener noreferrer">The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:35152405</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline siponimod">
          <h3 id="siponimod">siponimod</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-siponimod">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166211021" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C9: Siponimod is contraindicated in patients with this genetic variation. Theoretically, the risk of adverse effects is greatly increased, as the genetic variation results in much higher plasma concentrations of siponimod.</td>
                        <td class="drugRecommendation">Avoid siponimod.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
        </section>
      
        <section class="guideline streptomycin">
          <h3 id="streptomycin">streptomycin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-streptomycin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline succinylcholine">
          <h3 id="succinylcholine">succinylcholine</h3>

          
            <div class="alert alert-info Malignant-Hyperthermia-Susceptibility-warning">If the summary table (Section I) includes Malignant Hyperthermia Susceptibility as phenotype for either RYR1 or CACNA1S, please refer to the guideline publication PMID:30499100 (link below) since halogenated volatile anesthetics or depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with Malignant Hyperthermia Susceptibility.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-succinylcholine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CACNA1S">CACNA1S</a>:<br />No CPIC variants found</span>;<br /><span class="rx-dip"><a href="#RYR1">RYR1</a>:<br />No CPIC variants found</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>Uncertain Susceptibility</dd><dt>RYR1:</dt><dd>Uncertain Susceptibility</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CACNA1S:</dt><dd>N/A</dd><dt>RYR1:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CACNA1S: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li><li>RYR1: These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).</li></ul></td>
                        <td class="drugRecommendation">Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.</td>
                        <td>N/A</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30499100" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes</a>. <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30499100</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sulfadiazine">
          <h3 id="sulfadiazine">sulfadiazine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sulfadiazine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sulfadimidine">
          <h3 id="sulfadimidine">sulfadimidine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sulfadimidine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sulfamethoxazole_trimethoprim">
          <h3 id="sulfamethoxazole_trimethoprim">sulfamethoxazole / trimethoprim</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sulfamethoxazole_trimethoprim">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sulfanilamide">
          <h3 id="sulfanilamide">sulfanilamide</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sulfanilamide">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sulfasalazine">
          <h3 id="sulfasalazine">sulfasalazine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sulfasalazine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline sulfisoxazole">
          <h3 id="sulfisoxazole">sulfisoxazole</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-sulfisoxazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tacrolimus">
          <h3 id="tacrolimus">tacrolimus</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-tacrolimus">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A5">CYP3A5</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>N/A</p>
                        
                      </td>
                    
                        <td>CYP3A5: Higher ("normal") dose-adjusted trough concentrations of tacrolimus and increased chance of achieving target tacrolimus concentrations.</td>
                        <td class="drugRecommendation">Initiate therapy with standard recommended dose. Use therapeutic drug monitoring to guide dose adjustments.</td>
                        <td>This recommendation includes the use of tacrolimus in kidney, heart, lung and hematopoietic stem cell transplant patients, and liver transplant patients where the donor and recipient genotypes are identical. Typically with other CYP enzymes, a normal metabolizer would be classified as having normal metabolism, and therefore, the drug dose would not change based on the patient’s genotype. However, in the case of CYP3A5 and tacrolimus, a CYP3A5 expresser (i.e., CYP3A5 normal metabolizer or intermediate metabolizer) would require a higher recommended starting dose and the CYP3A5 non-expresser (i.e., poor metabolizer) would require the standard recommended starting dose.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-tacrolimus">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104983" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP3A5">CYP3A5</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td>CYP3A5: The guideline does not provide a description of the impact of a non-expressor phenotype on tacrolimus.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for tacrolimus in CYP3A5 non-expressers.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/25801146" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2015. PMID:25801146</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tafenoquine">
          <h3 id="tafenoquine">tafenoquine</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-tafenoquine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td>Tafenoquine’s safety has been established for a G6PD enzyme activity ≥70% of normal. (Inclusion criteria for clinical trials involving tafenoquine included G6PD activity ≥70%.)</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tamoxifen">
          <h3 id="tamoxifen">tamoxifen</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-tamoxifen">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-tamoxifen">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/29385237" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:29385237</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tegafur">
          <h3 id="tegafur">tegafur</h3>

          
            <div class="alert alert-info DPYD-lowest-activity-score-note">The two lowest activity values (variant activity scores, see CPIC guideline PMID: 29152729) are used for uphased data and the lowest activity value per allele are used for phased data to determine the gene activity score and phenotype to retrieve prescribing recommendations. </div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned dpwg-tegafur">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104944" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#DPYD">DPYD</a>:c.1627A>G (*5)/<br />c.1627A>G (*5)</span>
                                
                                <sup><a href="#rx-ddagger-tegafur" title="Inferred">&ddagger;</a></sup>
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>2</p>
                        
                      </td>
                    
                        <td>DPYD: The guideline does not provide a description of the impact of a DPYD activity score of 2 on tegafur.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for tegafur in patients with a DPYD activity score of 2.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          
            <div class="footnote" id="rx-ddagger-tegafur">
              <sup>&ddagger;</sup> The DPYD genotype used to look up phenotype is inferred from the two lowest function
              haplotypes. Consult the
              <a href="https://pharmcat.org/methods/Gene-Definition-Exceptions/#dpyd" target="_blank" rel="noopener noreferrer">PharmCAT documentation</a>
              for details.
            </div>
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/31745289" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.</a> <i>European journal of human genetics : EJHG</i>. 2019. PMID:31745289</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tenoxicam">
          <h3 id="tenoxicam">tenoxicam</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-tenoxicam">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                          <div class="hint">Activity Score</div>
                          <p>0.0</p>
                        
                      </td>
                    
                        <td>CYP2C9: Significantly reduced metabolism and prolonged half-life; higher plasma concentrations may increase probability and/or severity of toxicities</td>
                        <td class="drugRecommendation">Choose an alternative therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo or choose an NSAID metabolized by CYP2C9 but with a shorter half-life (see CPIC THERAPEUTIC RECOMMENDATIONS FOR CELECOXIB, FLURBIPROFEN, LORNOXICAM, AND IBUPROFEN BASED ON CYP2C9 PHENOTYPE).</td>
                        <td>Alternative therapies not primarily metabolized by CYP2C9 include aspirin, ketorolac, naproxen and sulindac. Selection of therapy will depend on individual patient treatment goals and risks for toxicity.</td>
                        <td>Optional</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/32189324" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.</a> <i>Clinical pharmacology and therapeutics</i>. 2020. PMID:32189324</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline thioguanine">
          <h3 id="thioguanine">thioguanine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-thioguanine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>;<br /><span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>NUDT15:</dt><dd>Normal Metabolizer</dd><dt>TPMT:</dt><dd>Normal Metabolizer</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>NUDT15:</dt><dd>N/A</dd><dt>TPMT:</dt><dd>N/A</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>NUDT15: Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression</li><li>TPMT: Lower concentrations of TGN metabolites, but note that TGN after thioguanine are 5-10X higher than TGN after mercaptopurine or azathioprine. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression.</li></ul></td>
                        <td class="drugRecommendation">Start with normal starting dose (e.g., 40-60 mg/m2/day) and adjust doses of thioguanine and of other myelosuppressive therapy without any special emphasis on thioguanine. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11037857).</td>
                        <td>Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-thioguanine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184612" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104960" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#NUDT15">NUDT15</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>NUDT15: The guideline does not provide a description of the impact of a normal metabolizer phenotype on thioguanine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for thioguanine in normal metabolizers</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-thioguanine">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166184612" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104960" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#TPMT">TPMT</a>:*1/*1</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>TPMT: The guideline does not provide a description of the impact of a normal metabolizer phenotype on thioguanine.</td>
                        <td class="drugRecommendation">The guideline does not provide a recommendation for thioguanine in normal metabolizers.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21270794" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21270794</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23422873" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23422873</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/30447069" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.</a> <i>Clinical pharmacology and therapeutics</i>. 2018. PMID:30447069</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tobramycin">
          <h3 id="tobramycin">tobramycin</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-tobramycin">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for MT-RNR1</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34032273" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:34032273</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tolbutamide">
          <h3 id="tolbutamide">tolbutamide</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-tolbutamide">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline toluidine_blue">
          <h3 id="toluidine_blue">toluidine blue</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-toluidine_blue">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid ased on G6PD status</td>
                        <td>Toluidine blue classification strength is based on extrapolation from methylene blue data</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tramadol">
          <h3 id="tramadol">tramadol</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-tramadol">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-tramadol">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/22205192" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:22205192</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/24458010" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2014. PMID:24458010</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/33387367" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.</a> <i>Clinical pharmacology and therapeutics</i>. 2021. PMID:33387367</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34267337" target="_blank" rel="noopener noreferrer">Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).</a> <i>European journal of human genetics : EJHG</i>. 2022. PMID:34267337</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline trimipramine">
          <h3 id="trimipramine">trimipramine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-trimipramine">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>;<br /><span class="rx-dip"><a href="#CYP2D6">CYP2D6</a>:Unknown/Unknown</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotypes</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>Normal Metabolizer</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                        
                          <div class="hint">Activity Scores</div>
                          <dl class="compact mt-0"><dt>CYP2C19:</dt><dd>N/A</dd><dt>CYP2D6:</dt><dd>No Result</dd></dl>
                        
                      </td>
                    
                        <td><ul class="noPadding mt-0"><li>CYP2C19: Normal metabolism of tertiary amines</li><li>CYP2D6: N/A</li></ul></td>
                        <td class="drugRecommendation">Initiate therapy with recommended starting dose.</td>
                        <td>Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose.</td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/23486447" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants</a>. <i>Clinical pharmacology and therapeutics</i>. 2013. PMID:23486447</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27997040</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline tropisetron">
          <h3 id="tropisetron">tropisetron</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-tropisetron">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/28002639" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:28002639</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline venlafaxine">
          <h3 id="venlafaxine">venlafaxine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-venlafaxine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
              
                <tr class="top-aligned dpwg-venlafaxine">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline vitamin_c">
          <h3 id="vitamin_c">vitamin c</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-vitamin_c">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline vitamin_k">
          <h3 id="vitamin_k">vitamin k</h3>

          
            <div class="alert alert-info G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-vitamin_k">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/cpic-guideline-for-g6pd/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />general</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#G6PD">G6PD</a>:B (reference)/<br />B (reference)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal</p>
                        
                        
                      </td>
                    
                        <td>G6PD: Low-to-no risk of acute hemolytic anemia</td>
                        <td class="drugRecommendation">No reason to avoid based on G6PD status</td>
                        <td></td>
                        <td>Strong</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/36049896" target="_blank" rel="noopener noreferrer">Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.</a> <i>Clinical pharmacology and therapeutics</i>. 2022. PMID:36049896</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline voriconazole">
          <h3 id="voriconazole">voriconazole</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-voriconazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />adults</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Normal voriconazole metabolism</td>
                        <td class="drugRecommendation">Initiate therapy with recommended standard of care dosing</td>
                        <td>Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities.</td>
                        <td>Strong</td>
                    
                  
                    <tr class="top-aligned cpic-voriconazole">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />pediatrics</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Normal Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C19: Normal voriconazole metabolism</td>
                        <td class="drugRecommendation">Initiate therapy with recommended standard of care dosing</td>
                        <td>Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities.</td>
                        <td>Strong</td>
                    
                  
                
              
            
              
                <tr class="top-aligned dpwg-voriconazole">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                        <sup class="sources">
                          <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166104990" target="_blank" rel="noopener noreferrer">1</a>
                        </sup>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <div style="display: flex;">
                        <div style="margin-right: 1em; ">
                          <div class="hint">&nbsp;</div>
                          No annotation for:
                        </div>
                        <div>
                          <div class="hint">Genotype</div>
                          <span class="rx-unmatched-dip"><a href="#CYP2C19">CYP2C19</a>:*38/*38</span>
                          
                          
                        </div>
                      </div>
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/27981572" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy</a>. <i>Clinical pharmacology and therapeutics</i>. 2016. PMID:27981572</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline vortioxetine">
          <h3 id="vortioxetine">vortioxetine</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned cpic-vortioxetine">
                  <td class="top-aligned">
                    <p>
                      <b>CPIC</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/37032427" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.</a> <i>Clinical pharmacology and therapeutics</i>. 2023. PMID:37032427</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline warfarin">
          <h3 id="warfarin">warfarin</h3>

          
            <div class="alert alert-info CYP4F2-1-4-warning">The assigned genotype is *1/*4; however, *2/*3 cannot be ruled out without phased data.</div>
          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                
                  
                    <tr class="top-aligned cpic-warfarin">
                      <td>
                        <p>
                          <b>CPIC</b>
                          
                            <sup class="sources">
                              <a href="https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/" target="_blank" rel="noopener noreferrer">1</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>;<br /><span class="rx-dip"><a href="#CYP4F2">CYP4F2</a>:*1/*4</span>;<br /><span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 variant (T)/<br />rs9923231 variant (T)</span>;<br /><span class="rx-hl-var">rs12777823:G/G</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td colspan="4">
                          
                            <div class="alert alert-info pcat-cpic-warfarin-1-flowchart">Please follow the flow chart in figure 2 of the <a href="https://www.pharmgkb.org/guideline/PA166104949">CPIC warfarin guideline</a> to determine the appropriate dosing recommendation.</div>
                          
                            <div class="alert alert-info pcat-cpic-warfarin-2-vkorc1">The CPIC warfarin guideline only considers a single SNV in VKORC1 (rs9923231), which has varying frequency among different ancestral populations, and largely explains the differences in average dose requirements between people of European, African, and Asian descents. While other functional variants in VKORC1 have been associated with warfarin resistance (high dose requirements), there are currently no CPIC recommendations for how to use these other variants in warfarin dosing. An alternate name for rs9923231 is -1639G>A (note that VKORC1 is on the negative chromosomal strand, so displayed alleles are complemented). </div>
                          
                          <div class="warfarinFlowchart">
                            <img src="https://files.cpicpgx.org/images/warfarin/warfarin_recommendation_diagram.png"
                                alt="Figure 2 from the CPIC guideline for warfarin"/>
                          </div>
                        </td>
                    
                  
                
              
            
              
                
                  
                    <tr class="top-aligned dpwg-warfarin">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182842" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182841" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#CYP2C9">CYP2C9</a>:*3/*3</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                          <div class="hint">Phenotype</div>
                          <p>Poor Metabolizer</p>
                        
                        
                      </td>
                    
                        <td>CYP2C9: This gene variation reduces the conversion of warfarin to inactive metabolites. This can increase the risk of bleeding.</td>
                        <td class="drugRecommendation"><ol>
<li>use 20% of the standard initial dose. The genotype-specific initial dose and maintenance dose can be calculated using an algorithm, as used in EU-PACT: see <a rel="noopener noreferrer" href="https://www.knmp.nl/producten/gebruiksrecht-g-standaard/medicatiebewaking-g-standaard/background-information-pharmacogenetics" target="_blank">Algorithms coumarins</a>. From day 6 on the standard algorithm without genotype information can be used to calculate the dose.</li>
</ol></td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
                  
                    <tr class="top-aligned dpwg-warfarin">
                      <td>
                        <p>
                          <b>PharmGKB-DPWG</b>
                          
                            <sup class="sources">
                              <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182842" target="_blank" rel="noopener noreferrer">1</a>, <a href="https://www.pharmgkb.org/guidelineAnnotation/PA166182841" target="_blank" rel="noopener noreferrer">2</a>
                            </sup>
                          
                        </p>
                        <p>Population:<br />N/A</p>
                      </td>
                      <td>
                        <div class="hint">Genotype</div>
                        <ul class="noBullet mt-0">
                          
                            <li>
                              <span class="noWrap">
                                <span class="rx-dip"><a href="#VKORC1">VKORC1</a>:<br />rs9923231 variant (T)/<br />rs9923231 variant (T)</span>
                                
                                
                              </span>
                              
                            </li>
                          
                        </ul>
                        
                        
                      </td>
                    
                        <td>VKORC1: The genetic variation results in increased sensitivity to warfarin. This results in an increase in the risk of excessively severe inhibition of blood clotting (INR &gt; 4) during the
first month of the treatment.</td>
                        <td class="drugRecommendation">Use 60% of the standard initial dose.
The genotype-specific initial dose and maintenance dose can be calculated using an algorithm, as used in EU-PACT: see
https://www.knmp.nl/patientenzorg/medicatiebewaking/farmacogenetica.
From day 6 on the standard algorithm without genotype information can be used to calculate the dose.</td>
                        <td>N/A</td>
                        <td>N/A</td>
                    
                  
                
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21900891" target="_blank" rel="noopener noreferrer">Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing</a>. <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21900891</li>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/28198005" target="_blank" rel="noopener noreferrer">Clinical pharmacogenetics implementation consortium (cpic) guideline for pharmacogenetics-guided warfarin dosing: 2017 update</a>. <i>Clinical pharmacology and therapeutics</i>. 2017. PMID:28198005</li>
                
              </ul>
            </div>
          
        </section>
      
        <section class="guideline zuclopenthixol">
          <h3 id="zuclopenthixol">zuclopenthixol</h3>

          

          <table>
            <thead>
            <tr>
              <th>Guideline</th>
              <th>Genes</th>
              <th>Implications</th>
              <th>Recommendation</th>
              <th>Comments</th>
              <th>Classification</th>
            </tr>
            </thead>
            <tbody>
            
              
                <tr class="top-aligned dpwg-zuclopenthixol">
                  <td class="top-aligned">
                    <p>
                      <b>PharmGKB-DPWG</b>
                      
                    </p>
                  </td>
                  <td colspan="5" class="top-aligned">
                    
                      <span class="rx-no-call">No call data for CYP2D6</span>.
                    
                  </td>
                </tr>
              
            
            </tbody>
          </table>

          
          

          

          
            <div class="citations">
              <p>Citations:</p>
              <ul>
                
                  <li><a href="https://www.ncbi.nlm.nih.gov/pubmed/21412232" target="_blank" rel="noopener noreferrer">Pharmacogenetics: from bench to byte--an update of guidelines.</a> <i>Clinical pharmacology and therapeutics</i>. 2011. PMID:21412232</li>
                
              </ul>
            </div>
          
        </section>
      
    
  </section>


  <section id="section-iii">
    <h2>Section III: Allele Matching Details</h2>

    
      <ol>
        
          <li><a href="#ABCG2">ABCG2 allele match data</a></li>
        
          <li><a href="#CACNA1S">CACNA1S allele match data</a></li>
        
          <li><a href="#CFTR">CFTR allele match data</a></li>
        
          <li><a href="#CYP2B6">CYP2B6 allele match data</a></li>
        
          <li><a href="#CYP2C19">CYP2C19 allele match data</a></li>
        
          <li><a href="#CYP2C9">CYP2C9 allele match data</a></li>
        
          <li><a href="#CYP3A4">CYP3A4 allele match data</a></li>
        
          <li><a href="#CYP3A5">CYP3A5 allele match data</a></li>
        
          <li><a href="#CYP4F2">CYP4F2 allele match data</a></li>
        
          <li><a href="#DPYD">DPYD allele match data</a></li>
        
          <li><a href="#F5">F5 allele match data</a></li>
        
          <li><a href="#G6PD">G6PD allele match data</a></li>
        
          <li><a href="#IFNL3/4">IFNL3/4 allele match data</a></li>
        
          <li><a href="#NUDT15">NUDT15 allele match data</a></li>
        
          <li><a href="#RYR1">RYR1 allele match data</a></li>
        
          <li><a href="#SLCO1B1">SLCO1B1 allele match data</a></li>
        
          <li><a href="#TPMT">TPMT allele match data</a></li>
        
          <li><a href="#UGT1A1">UGT1A1 allele match data</a></li>
        
          <li><a href="#VKORC1">VKORC1 allele match data</a></li>
        
      </ol>
    
    
      <p class="noGeneData">No data provided for <span class="gene cyp2d6"><span class="no-data">CYP2D6</span></span>, <span class="gene hla-a"><span class="no-data">HLA-A</span></span>, <span class="gene hla-b"><span class="no-data">HLA-B</span></span>, <span class="gene mt-rnr1"><span class="no-data">MT-RNR1</span></span>.</p>
    


    
      <section class="gene ABCG2">
        <h3 id="ABCG2">ABCG2 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs2231142 reference (G)/rs2231142 variant (T)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr4_88131171">chr4:88131171</td>
                  <td id="rs2231142">rs2231142</td>
                  
                  
                    <td class="nonwild">G/T</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    rs2231142 variant (T) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CACNA1S">
        <h3 id="CACNA1S">CACNA1S allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  No CPIC variants found
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The CACNA1S Reference allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr1_201060815">chr1:201060815</td>
                  <td id="rs1800559">rs1800559</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.3257G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_201091993">chr1:201091993</td>
                  <td id="rs772226819">rs772226819</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.520C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CFTR">
        <h3 id="CFTR">CFTR allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  No CPIC variants found
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr7_117509035">chr7:117509035</td>
                  <td id="rs397508256">rs397508256</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    E56K 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117509069">chr7:117509069</td>
                  <td id="rs368505753">rs368505753</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    P67L 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117509089">chr7:117509089</td>
                  <td id="rs115545701">rs115545701</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    R74W 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117530953">chr7:117530953</td>
                  <td id="rs113993958">rs113993958</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    D110H 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117530955">chr7:117530955</td>
                  <td id="rs397508537">rs397508537</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    D110E 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117530974">chr7:117530974</td>
                  <td id="rs77834169">rs77834169</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    R117C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117530975">chr7:117530975</td>
                  <td id="rs78655421">rs78655421</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    R117H 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117534318">chr7:117534318</td>
                  <td id="rs80282562">rs80282562</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    G178R 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117534363">chr7:117534363</td>
                  <td id="rs397508759">rs397508759</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    E193K 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117534368">chr7:117534368</td>
                  <td id="rs397508761">rs397508761</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    711+3A-&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117535285">chr7:117535285</td>
                  <td id="rs121908752">rs121908752</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    L206W 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117540270">chr7:117540270</td>
                  <td id="rs77932196">rs77932196</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    R347H 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117540285">chr7:117540285</td>
                  <td id="rs121908753">rs121908753</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    R352Q 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117548795">chr7:117548795</td>
                  <td id="rs74551128">rs74551128</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    A455E 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117587799">chr7:117587799</td>
                  <td id="rs121908757">rs121908757</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    S549R(A&gt;C) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117587800">chr7:117587800</td>
                  <td id="rs121908755">rs121908755</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    S549N 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117587801">chr7:117587801</td>
                  <td id="rs121909005">rs121909005</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    S549R(T&gt;G) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117587805">chr7:117587805</td>
                  <td id="rs121909013">rs121909013</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    G551S 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117587806">chr7:117587806</td>
                  <td id="rs75527207">rs75527207</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    G551D 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117590409">chr7:117590409</td>
                  <td id="rs397508288">rs397508288</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    D579G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117594930">chr7:117594930</td>
                  <td id="rs397508387">rs397508387</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    E831X 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117602868">chr7:117602868</td>
                  <td id="rs80224560">rs80224560</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    2789+5G-&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117603708">chr7:117603708</td>
                  <td id="rs397508442">rs397508442</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    S945L 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117606695">chr7:117606695</td>
                  <td id="rs141033578">rs141033578</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    S977F 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611555">chr7:117611555</td>
                  <td id="rs76151804">rs76151804</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    3272-26A-&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611595">chr7:117611595</td>
                  <td id="rs150212784">rs150212784</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    F1052V 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611620">chr7:117611620</td>
                  <td id="rs397508513">rs397508513</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    K1060T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611640">chr7:117611640</td>
                  <td id="rs121909020">rs121909020</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    A1067T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611646">chr7:117611646</td>
                  <td id="rs200321110">rs200321110</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    G1069R 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611649">chr7:117611649</td>
                  <td id="rs202179988">rs202179988</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    R1070W 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611650">chr7:117611650</td>
                  <td id="rs78769542">rs78769542</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    R1070Q 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117611663">chr7:117611663</td>
                  <td id="rs186045772">rs186045772</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    F1074L 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117614699">chr7:117614699</td>
                  <td id="rs75541969">rs75541969</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    D1152H 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117639961">chr7:117639961</td>
                  <td id="rs75039782">rs75039782</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    3849+10kbC-&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117642451">chr7:117642451</td>
                  <td id="rs267606723">rs267606723</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    G1244E 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117642472">chr7:117642472</td>
                  <td id="rs74503330">rs74503330</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    S1251N 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117642483">chr7:117642483</td>
                  <td id="rs121909041">rs121909041</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    S1255P 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117642528">chr7:117642528</td>
                  <td id="rs11971167">rs11971167</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    D1270N 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_117664770">chr7:117664770</td>
                  <td id="rs193922525">rs193922525</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    G1349D 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP2B6">
        <h3 id="CYP2B6">CYP2B6 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *9/*9
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr19_40991224">chr19:40991224</td>
                  <td id="rs34223104">rs34223104</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *22 *34 *35 *36 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991367">chr19:40991367</td>
                  <td id="rs34883432">rs34883432</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991369">chr19:40991369</td>
                  <td id="rs8192709">rs8192709</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *2 *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991381">chr19:40991381</td>
                  <td id="rs33973337">rs33973337</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991388">chr19:40991388</td>
                  <td id="rs33980385">rs33980385</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991390">chr19:40991390</td>
                  <td id="rs33926104">rs33926104</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991391">chr19:40991391</td>
                  <td id="rs34284776">rs34284776</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_40991441">chr19:40991441</td>
                  <td id="rs35303484">rs35303484</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *11 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004015">chr19:41004015</td>
                  <td id="rs281864907">rs281864907</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *38 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004125">chr19:41004125</td>
                  <td id="rs36060847">rs36060847</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004133">chr19:41004133</td>
                  <td id="rs148009906">rs148009906</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *44 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004158">chr19:41004158</td>
                  <td id="rs186335453">rs186335453</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004303">chr19:41004303</td>
                  <td id="rs139801276">rs139801276</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004377">chr19:41004377</td>
                  <td id="rs12721655">rs12721655</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *8 *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004380">chr19:41004380</td>
                  <td id="rs535039125">rs535039125</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004381">chr19:41004381</td>
                  <td id="rs35773040">rs35773040</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *14 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41004406">chr19:41004406</td>
                  <td id="rs145884402">rs145884402</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41006919">chr19:41006919</td>
                  <td id="rs3826711">rs3826711</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *26 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41006923">chr19:41006923</td>
                  <td id="rs36056539">rs36056539</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *20 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41006936">chr19:41006936</td>
                  <td id="rs3745274">rs3745274</td>
                  
                  
                    <td class="nonwild">T/T</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *6 *7 *9 *13 *19 *20 *26 *34 *36 *37 *38 *39 *40 *41 *42 *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41006967">chr19:41006967</td>
                  <td id="rs58871670">rs58871670</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *45 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41006968">chr19:41006968</td>
                  <td id="rs373489637">rs373489637</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *37 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41007013">chr19:41007013</td>
                  <td id="rs36079186">rs36079186</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *27 *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41009313">chr19:41009313</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *46 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41009350">chr19:41009350</td>
                  <td id="rs45482602">rs45482602</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *3 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41009358">chr19:41009358</td>
                  <td id="rs2279343">rs2279343</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *4 *6 *7 *13 *18 *19 *20 *26 *34 *36 *37 *38 *39 *40 *41 *42 *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41010006">chr19:41010006</td>
                  <td id="rs139029625">rs139029625</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41010088">chr19:41010088</td>
                  <td id="rs34698757">rs34698757</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *28 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41010108">chr19:41010108</td>
                  <td id="rs193922917">rs193922917</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *31 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012316">chr19:41012316</td>
                  <td id="rs28399499">rs28399499</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *18 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012339">chr19:41012339</td>
                  <td id="rs34826503">rs34826503</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *19 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012393">chr19:41012393</td>
                  <td id="rs754621576">rs754621576</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *47 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012394">chr19:41012394</td>
                  <td id="rs780991919">rs780991919</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *47 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012465">chr19:41012465</td>
                  <td id="rs34097093">rs34097093</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *28 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012466">chr19:41012466</td>
                  <td id="rs200458614">rs200458614</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *40 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012471">chr19:41012471</td>
                  <td id="rs201500445">rs201500445</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *41 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012478">chr19:41012478</td>
                  <td id="rs200238771">rs200238771</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *48 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012693">chr19:41012693</td>
                  <td id="rs35979566">rs35979566</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *15 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012740">chr19:41012740</td>
                  <td id="rs193922918">rs193922918</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *32 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41012803">chr19:41012803</td>
                  <td id="rs35010098">rs35010098</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *21 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016652">chr19:41016652</td>
                  <td id="rs764288403">rs764288403</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *49 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016679">chr19:41016679</td>
                  <td id="rs374099483">rs374099483</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *42 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016726">chr19:41016726</td>
                  <td id="rs3211369">rs3211369</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *23 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016741">chr19:41016741</td>
                  <td id="rs117872433">rs117872433</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016778">chr19:41016778</td>
                  <td id="rs564083989">rs564083989</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *24 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016805">chr19:41016805</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *25 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_41016810">chr19:41016810</td>
                  <td id="rs3211371">rs3211371</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *5 *7 *33 *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP2C19">
        <h3 id="CYP2C19">CYP2C19 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *38/*38
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The CYP2C19 *38 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr10_94761900">chr10:94761900</td>
                  <td id="rs12248560">rs12248560</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *4 *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762706">chr10:94762706</td>
                  <td id="rs28399504">rs28399504</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762712">chr10:94762712</td>
                  <td id="rs367543002">rs367543002</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762715">chr10:94762715</td>
                  <td id="rs367543003">rs367543003</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *1 *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762755">chr10:94762755</td>
                  <td id="rs55752064">rs55752064</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *1 *14 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762760">chr10:94762760</td>
                  <td id="rs17882687">rs17882687</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *15 *28 *35 *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762788">chr10:94762788</td>
                  <td id="rs1564656981">rs1564656981</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *29 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94762856">chr10:94762856</td>
                  <td id="rs1564657013">rs1564657013</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *19 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775106">chr10:94775106</td>
                  <td id="rs145328984">rs145328984</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *30 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775121">chr10:94775121</td>
                  <td id="rs1564660997">rs1564660997</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *31 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775160">chr10:94775160</td>
                  <td id="rs118203756">rs118203756</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *23 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775185">chr10:94775185</td>
                  <td id="rs1288601658">rs1288601658</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *32 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775367">chr10:94775367</td>
                  <td id="rs12769205">rs12769205</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *2 *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775416">chr10:94775416</td>
                  <td id="rs41291556">rs41291556</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *1 *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775423">chr10:94775423</td>
                  <td id="rs17885179">rs17885179</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775453">chr10:94775453</td>
                  <td id="rs72552267">rs72552267</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775489">chr10:94775489</td>
                  <td id="rs17884712">rs17884712</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94775507">chr10:94775507</td>
                  <td id="rs58973490">rs58973490</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *2 *11 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94780574">chr10:94780574</td>
                  <td id="rs140278421">rs140278421</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *22 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94780579">chr10:94780579</td>
                  <td id="rs370803989">rs370803989</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *33 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94780653">chr10:94780653</td>
                  <td id="rs4986893">rs4986893</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *3 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94781858">chr10:94781858</td>
                  <td id="rs6413438">rs6413438</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94781859">chr10:94781859</td>
                  <td id="rs4244285">rs4244285</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *2 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94781944">chr10:94781944</td>
                  <td id="rs375781227">rs375781227</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *26 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94781999">chr10:94781999</td>
                  <td id="rs72558186">rs72558186</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *1 *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94842861">chr10:94842861</td>
                  <td id="rs138142612">rs138142612</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *18 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94842866">chr10:94842866</td>
                  <td id="rs3758581">rs3758581</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *2 *3 *4 *5 *6 *7 *8 *9 *10 *11 *12 *13 *14 *15 *17 *18 *19 *22 *23 *24 *25 *26 *28 *29 *31 *32 *33 *35 *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94842879">chr10:94842879</td>
                  <td id="rs118203757">rs118203757</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *24 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94842995">chr10:94842995</td>
                  <td id="rs113934938">rs113934938</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *1 *28 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94849995">chr10:94849995</td>
                  <td id="rs17879685">rs17879685</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94852738">chr10:94852738</td>
                  <td id="rs56337013">rs56337013</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94852765">chr10:94852765</td>
                  <td id="rs192154563">rs192154563</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *16 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94852785">chr10:94852785</td>
                  <td id="rs118203759">rs118203759</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *1 *25 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94852914">chr10:94852914</td>
                  <td id="rs55640102">rs55640102</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *1 *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP2C9">
        <h3 id="CYP2C9">CYP2C9 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *3/*3
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr10_94938683">chr10:94938683</td>
                  <td id="rs114071557">rs114071557</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *36 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938719">chr10:94938719</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *80 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938737">chr10:94938737</td>
                  <td id="rs67807361">rs67807361</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938771">chr10:94938771</td>
                  <td id="rs142240658">rs142240658</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *21 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938788">chr10:94938788</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *83 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938800">chr10:94938800</td>
                  <td id="rs1364419386">rs1364419386</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *76 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938803">chr10:94938803</td>
                  <td id="rs2031308986">rs2031308986</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *22 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94938828">chr10:94938828</td>
                  <td id="rs564813580">rs564813580</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *37 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94941897">chr10:94941897</td>
                  <td id="rs371055887">rs371055887</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *20 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94941915">chr10:94941915</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *23 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94941958">chr10:94941958</td>
                  <td id="rs72558187">rs72558187</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94941975">chr10:94941975</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *77 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94941976">chr10:94941976</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *38 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94941982">chr10:94941982</td>
                  <td id="rs762239445">rs762239445</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942018">chr10:94942018</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *40 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942205">chr10:94942205</td>
                  <td id="rs1304490498">rs1304490498</td>
                  
                  
                    <td class="">CAATGGAAA<br />GA|CAATGG<br />AAAGA</td>
                  
                  <td>
                    CAATGGAAA<br />GA
                  </td>
                  <td>
                    *25 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942216">chr10:94942216</td>
                  <td id="rs774607211">rs774607211</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *41 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942230">chr10:94942230</td>
                  <td id="rs767576260">rs767576260</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942231">chr10:94942231</td>
                  <td id="rs12414460">rs12414460</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *42 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942233">chr10:94942233</td>
                  <td id="rs375805362">rs375805362</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *62 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942234">chr10:94942234</td>
                  <td id="rs72558189">rs72558189</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *14 *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942243">chr10:94942243</td>
                  <td id="rs1375956433">rs1375956433</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *78 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942249">chr10:94942249</td>
                  <td id="rs200965026">rs200965026</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *26 *44 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942254">chr10:94942254</td>
                  <td id="rs199523631">rs199523631</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *45 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942255">chr10:94942255</td>
                  <td id="rs200183364">rs200183364</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *33 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942290">chr10:94942290</td>
                  <td id="rs1799853">rs1799853</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *2 *35 *61 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942291">chr10:94942291</td>
                  <td id="rs141489852">rs141489852</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *63 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942305">chr10:94942305</td>
                  <td id="rs754487195">rs754487195</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *46 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942306">chr10:94942306</td>
                  <td id="rs1289704600">rs1289704600</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *72 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942308">chr10:94942308</td>
                  <td id="rs17847037">rs17847037</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *73 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94942309">chr10:94942309</td>
                  <td id="rs7900194">rs7900194</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *8 *27 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947782">chr10:94947782</td>
                  <td id="rs72558190">rs72558190</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *15 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947785">chr10:94947785</td>
                  <td id="rs774550549">rs774550549</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *47 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947869">chr10:94947869</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *69 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947907">chr10:94947907</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *57 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947917">chr10:94947917</td>
                  <td id="rs1326630788">rs1326630788</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *48 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947938">chr10:94947938</td>
                  <td id="rs2031531005">rs2031531005</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *28 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94947939">chr10:94947939</td>
                  <td id="rs370100007">rs370100007</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *74 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949129">chr10:94949129</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *49 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949144">chr10:94949144</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *50 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949145">chr10:94949145</td>
                  <td id="rs772782449">rs772782449</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *82 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949161">chr10:94949161</td>
                  <td id=""></td>
                  
                  
                    <td class="">AT|AT</td>
                  
                  <td>
                    AT
                  </td>
                  <td>
                    *85 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949217">chr10:94949217</td>
                  <td id="rs2256871">rs2256871</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949280">chr10:94949280</td>
                  <td id="rs9332130">rs9332130</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *10 *71 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94949281">chr10:94949281</td>
                  <td id="rs9332131">rs9332131</td>
                  
                  
                    <td class="">GA|GA</td>
                  
                  <td>
                    GA
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972119">chr10:94972119</td>
                  <td id="rs182132442">rs182132442</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *29 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972123">chr10:94972123</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *64 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972134">chr10:94972134</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *51 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972179">chr10:94972179</td>
                  <td id="rs72558192">rs72558192</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *16 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972180">chr10:94972180</td>
                  <td id="rs988617574">rs988617574</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *52 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972183">chr10:94972183</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *81 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94972233">chr10:94972233</td>
                  <td id="rs1237225311">rs1237225311</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *53 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981199">chr10:94981199</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *65 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981201">chr10:94981201</td>
                  <td id="rs57505750">rs57505750</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *31 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981224">chr10:94981224</td>
                  <td id="rs28371685">rs28371685</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *11 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981225">chr10:94981225</td>
                  <td id="rs367826293">rs367826293</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981230">chr10:94981230</td>
                  <td id="rs1274535931">rs1274535931</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *58 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981250">chr10:94981250</td>
                  <td id="rs750820937">rs750820937</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *54 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981258">chr10:94981258</td>
                  <td id="rs1297714792">rs1297714792</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *79 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981281">chr10:94981281</td>
                  <td id="rs749060448">rs749060448</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *24 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981296">chr10:94981296</td>
                  <td id="rs1057910">rs1057910</td>
                  
                  
                    <td class="nonwild">C/C</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *3 *18 *68 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981297">chr10:94981297</td>
                  <td id="rs56165452">rs56165452</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981301">chr10:94981301</td>
                  <td id="rs28371686">rs28371686</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981302">chr10:94981302</td>
                  <td id="rs1250577724">rs1250577724</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *55 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981305">chr10:94981305</td>
                  <td id="rs578144976">rs578144976</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *66 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981365">chr10:94981365</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94981371">chr10:94981371</td>
                  <td id="rs542577750">rs542577750</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *68 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94986042">chr10:94986042</td>
                  <td id="rs764211126">rs764211126</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *56 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94986073">chr10:94986073</td>
                  <td id="rs72558193">rs72558193</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *18 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94986136">chr10:94986136</td>
                  <td id="rs1254213342">rs1254213342</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *75 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94986174">chr10:94986174</td>
                  <td id="rs1441296358">rs1441296358</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *84 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988852">chr10:94988852</td>
                  <td id="rs776908257">rs776908257</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *67 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988855">chr10:94988855</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *59 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988880">chr10:94988880</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *70 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988917">chr10:94988917</td>
                  <td id="rs769942899">rs769942899</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *19 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988925">chr10:94988925</td>
                  <td id="rs202201137">rs202201137</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *61 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988955">chr10:94988955</td>
                  <td id="rs767284820">rs767284820</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *60 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94988984">chr10:94988984</td>
                  <td id="rs781583846">rs781583846</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *30 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94989020">chr10:94989020</td>
                  <td id="rs9332239">rs9332239</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *12 *71 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr10_94989023">chr10:94989023</td>
                  <td id="rs868182778">rs868182778</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *32 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          
            <h4>Other Positions of Interest</h4>
            
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="94645745">chr10:94645745</td>
                  <td id="rs12777823">rs12777823</td>
                  
                  
                    <td class="">G|G</td>
                  
                </tr>
              
              </tbody>
            </table>
          

        

      </section>
    
      <section class="gene CYP3A4">
        <h3 id="CYP3A4">CYP3A4 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning CYP3A4">The CYP3A4 alleles are determined based on PharmVar CYP3A4 allele definitions. See PharmCAT disclaimer for further information.</div>
        
          <div class="alert alert-warning reference-allele">The CYP3A4 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr7_99758183">chr7:99758183</td>
                  <td id="rs67666821">rs67666821</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *20 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99760836">chr7:99760836</td>
                  <td id="rs4986913">rs4986913</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *19 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99760901">chr7:99760901</td>
                  <td id="rs4986910">rs4986910</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *3 *37 *38 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99760956">chr7:99760956</td>
                  <td id="rs774109750">rs774109750</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99762047">chr7:99762047</td>
                  <td id="rs4986909">rs4986909</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99762177">chr7:99762177</td>
                  <td id="rs12721629">rs12721629</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99762186">chr7:99762186</td>
                  <td id="rs756833413">rs756833413</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *33 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99762206">chr7:99762206</td>
                  <td id="rs67784355">rs67784355</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *11 *38 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99763877">chr7:99763877</td>
                  <td id="rs368296206">rs368296206</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *32 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99763909">chr7:99763909</td>
                  <td id="rs1303250043">rs1303250043</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *31 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99763925">chr7:99763925</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *21 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99764003">chr7:99764003</td>
                  <td id="rs28371759">rs28371759</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *18 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99766411">chr7:99766411</td>
                  <td id="rs4646438">rs4646438</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99766440">chr7:99766440</td>
                  <td id="rs138105638">rs138105638</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *26 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99768360">chr7:99768360</td>
                  <td id="rs55785340">rs55785340</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *2 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99768371">chr7:99768371</td>
                  <td id="rs55901263">rs55901263</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99768424">chr7:99768424</td>
                  <td id="rs113667357">rs113667357</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *24 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99768458">chr7:99768458</td>
                  <td id="rs4987161">rs4987161</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99768470">chr7:99768470</td>
                  <td id="rs12721627">rs12721627</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *16 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99768693">chr7:99768693</td>
                  <td id="rs35599367">rs35599367</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *22 *37 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99769769">chr7:99769769</td>
                  <td id="rs4986908">rs4986908</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99769781">chr7:99769781</td>
                  <td id="rs72552798">rs72552798</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99769804">chr7:99769804</td>
                  <td id="rs4986907">rs4986907</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *15 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99769805">chr7:99769805</td>
                  <td id="rs57409622">rs57409622</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *23 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99770165">chr7:99770165</td>
                  <td id="rs72552799">rs72552799</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99770166">chr7:99770166</td>
                  <td id="rs778013004">rs778013004</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *30 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99770202">chr7:99770202</td>
                  <td id="rs55951658">rs55951658</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99770217">chr7:99770217</td>
                  <td id="rs1449865051">rs1449865051</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *29 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99778079">chr7:99778079</td>
                  <td id="rs56324128">rs56324128</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99784018">chr7:99784018</td>
                  <td id="rs570051168">rs570051168</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *28 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99784038">chr7:99784038</td>
                  <td id="rs12721634">rs12721634</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *14 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99784075">chr7:99784075</td>
                  <td id="rs188389063">rs188389063</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP3A5">
        <h3 id="CYP3A5">CYP3A5 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *3/*3
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr7_99652770">chr7:99652770</td>
                  <td id="rs41303343">rs41303343</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99660516">chr7:99660516</td>
                  <td id="rs28383479">rs28383479</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99665212">chr7:99665212</td>
                  <td id="rs10264272">rs10264272</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99672916">chr7:99672916</td>
                  <td id="rs776746">rs776746</td>
                  
                  
                    <td class="nonwild">C/C</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *3 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr7_99676198">chr7:99676198</td>
                  <td id="rs55817950">rs55817950</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene CYP4F2">
        <h3 id="CYP4F2">CYP4F2 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*4
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning CYP4F2-1-4-warning">The assigned genotype is *1/*4; however, *2/*3 cannot be ruled out without phased data.</div>
        
          <div class="alert alert-warning reference-allele">The CYP4F2 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr19_15878779">chr19:15878779</td>
                  <td id="rs3093200">rs3093200</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15879412">chr19:15879412</td>
                  <td id="rs138971789">rs138971789</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *15 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15879621">chr19:15879621</td>
                  <td id="rs2108622">rs2108622</td>
                  
                  
                    <td class="nonwild">C/T</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *3 *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15886018">chr19:15886018</td>
                  <td id="rs145174239">rs145174239</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *14 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15889671">chr19:15889671</td>
                  <td id="rs144233412">rs144233412</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15890405">chr19:15890405</td>
                  <td id="rs3093153">rs3093153</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15892541">chr19:15892541</td>
                  <td id="rs145875499">rs145875499</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15895527">chr19:15895527</td>
                  <td id="rs114396708">rs114396708</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *11 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15895560">chr19:15895560</td>
                  <td id="rs144455532">rs144455532</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15897466">chr19:15897466</td>
                  <td id="rs201380574">rs201380574</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15897473">chr19:15897473</td>
                  <td id="rs115517770">rs115517770</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15897566">chr19:15897566</td>
                  <td id="rs114099324">rs114099324</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_15897578">chr19:15897578</td>
                  <td id="rs3093105">rs3093105</td>
                  
                  
                    <td class="nonwild">A/C</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *2 *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene DPYD">
        <h3 id="DPYD">DPYD allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  c.1627A&gt;G (*5)/c.1627A&gt;G (*5)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning DPYD-lowest-activity-score-note">The two lowest activity values (variant activity scores, see CPIC guideline PMID: 29152729) are used for uphased data and the lowest activity value per allele are used for phased data to determine the gene activity score and phenotype to retrieve prescribing recommendations. </div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr1_97078987">chr1:97078987</td>
                  <td id="rs114096998">rs114096998</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.3067C&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97078993">chr1:97078993</td>
                  <td id="rs148799944">rs148799944</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.3061G&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079005">chr1:97079005</td>
                  <td id="rs140114515">rs140114515</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.3049G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079071">chr1:97079071</td>
                  <td id="rs1801268">rs1801268</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2983G&gt;T (*10) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079076">chr1:97079076</td>
                  <td id="rs139459586">rs139459586</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.2978T&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079077">chr1:97079077</td>
                  <td id="rs202144771">rs202144771</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.2977C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079121">chr1:97079121</td>
                  <td id="rs72547601">rs72547601</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2933A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079133">chr1:97079133</td>
                  <td id="rs72547602">rs72547602</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2921A&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97079139">chr1:97079139</td>
                  <td id="rs145529148">rs145529148</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2915A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97082365">chr1:97082365</td>
                  <td id="rs141044036">rs141044036</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2872A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97082391">chr1:97082391</td>
                  <td id="rs67376798">rs67376798</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2846A&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97098598">chr1:97098598</td>
                  <td id="rs1801267">rs1801267</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2657G&gt;A (*9B) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97098599">chr1:97098599</td>
                  <td id="rs147545709">rs147545709</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.2656C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97098616">chr1:97098616</td>
                  <td id="rs55674432">rs55674432</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2639G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97098632">chr1:97098632</td>
                  <td id="rs201035051">rs201035051</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2623A&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97193109">chr1:97193109</td>
                  <td id="rs60139309">rs60139309</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.2582A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97193209">chr1:97193209</td>
                  <td id="rs200687447">rs200687447</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2482G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97234958">chr1:97234958</td>
                  <td id="rs199634007">rs199634007</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.2336C&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97234991">chr1:97234991</td>
                  <td id="rs56005131">rs56005131</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.2303C&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97305279">chr1:97305279</td>
                  <td id="rs112766203">rs112766203</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.2279C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97305363">chr1:97305363</td>
                  <td id="rs60511679">rs60511679</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.2195T&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97305364">chr1:97305364</td>
                  <td id="rs1801160">rs1801160</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2194G&gt;A (*6) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97305372">chr1:97305372</td>
                  <td id="rs146529561">rs146529561</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.2186C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97306195">chr1:97306195</td>
                  <td id="rs145548112">rs145548112</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2161G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97373598">chr1:97373598</td>
                  <td id="rs137999090">rs137999090</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.2021G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97373629">chr1:97373629</td>
                  <td id="rs138545885">rs138545885</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1990G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97382461">chr1:97382461</td>
                  <td id="rs55971861">rs55971861</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.1906A&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450058">chr1:97450058</td>
                  <td id="rs3918290">rs3918290</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1905+1G&gt;A (*2A) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450059">chr1:97450059</td>
                  <td id="rs3918289">rs3918289</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1905C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450065">chr1:97450065</td>
                  <td id="rs72549303">rs72549303</td>
                  
                  
                    <td class="">TG|TG</td>
                  
                  <td>
                    TG
                  </td>
                  <td>
                    c.1898delC (*3) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450068">chr1:97450068</td>
                  <td id="rs17376848">rs17376848</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.1896T&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450168">chr1:97450168</td>
                  <td id="rs147601618">rs147601618</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.1796T&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450187">chr1:97450187</td>
                  <td id="rs145773863">rs145773863</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1777G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450189">chr1:97450189</td>
                  <td id="rs138616379">rs138616379</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1775G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97450190">chr1:97450190</td>
                  <td id="rs59086055">rs59086055</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1774C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515784">chr1:97515784</td>
                  <td id="rs201615754">rs201615754</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1682G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515787">chr1:97515787</td>
                  <td id="rs55886062">rs55886062</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.1679T&gt;G (*13) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515839">chr1:97515839</td>
                  <td id="rs1801159">rs1801159</td>
                  
                  
                    <td class="nonwild">C/C</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.1627A&gt;G (*5) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515851">chr1:97515851</td>
                  <td id="rs142619737">rs142619737</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1615G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515865">chr1:97515865</td>
                  <td id="rs1801158">rs1801158</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1601G&gt;A (*4) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515889">chr1:97515889</td>
                  <td id="rs190951787">rs190951787</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1577C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97515923">chr1:97515923</td>
                  <td id="rs148994843">rs148994843</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1543G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549565">chr1:97549565</td>
                  <td id="rs138391898">rs138391898</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1519G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549600">chr1:97549600</td>
                  <td id="rs111858276">rs111858276</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.1484A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549609">chr1:97549609</td>
                  <td id="rs72549304">rs72549304</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1475C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549681">chr1:97549681</td>
                  <td id="rs199549923">rs199549923</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1403C&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549713">chr1:97549713</td>
                  <td id="rs57918000">rs57918000</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1371C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549726">chr1:97549726</td>
                  <td id="rs144395748">rs144395748</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1358C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97549735">chr1:97549735</td>
                  <td id="rs72975710">rs72975710</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1349C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573785">chr1:97573785</td>
                  <td id="rs186169810">rs186169810</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.1314T&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573805">chr1:97573805</td>
                  <td id="rs142512579">rs142512579</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1294G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573821">chr1:97573821</td>
                  <td id="rs764666241">rs764666241</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1278G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573839">chr1:97573839</td>
                  <td id="rs200064537">rs200064537</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.1260T&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573863">chr1:97573863</td>
                  <td id="rs56038477">rs56038477</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1129-5923C&gt;G, c.1236G&gt;A (HapB3) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573881">chr1:97573881</td>
                  <td id="rs61622928">rs61622928</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1218G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573918">chr1:97573918</td>
                  <td id="rs143815742">rs143815742</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1181G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573919">chr1:97573919</td>
                  <td id="rs140602333">rs140602333</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1180C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97573943">chr1:97573943</td>
                  <td id="rs78060119">rs78060119</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1156G&gt;T (*12) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97579893">chr1:97579893</td>
                  <td id="rs75017182">rs75017182</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1129-5923C&gt;G, c.1236G&gt;A (HapB3) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97593238">chr1:97593238</td>
                  <td id="rs72549305">rs72549305</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.1108A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97593289">chr1:97593289</td>
                  <td id="rs143154602">rs143154602</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1057C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97593322">chr1:97593322</td>
                  <td id="rs183385770">rs183385770</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1024G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97593343">chr1:97593343</td>
                  <td id="rs72549306">rs72549306</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1003G&gt;T (*11) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97593379">chr1:97593379</td>
                  <td id="rs201018345">rs201018345</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.967G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97595083">chr1:97595083</td>
                  <td id="rs145112791">rs145112791</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.934C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97595088">chr1:97595088</td>
                  <td id="rs150437414">rs150437414</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.929T&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97595149">chr1:97595149</td>
                  <td id="rs146356975">rs146356975</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.868A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97679170">chr1:97679170</td>
                  <td id="rs45589337">rs45589337</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.775A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97691776">chr1:97691776</td>
                  <td id="rs1801266">rs1801266</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.703C&gt;T (*8) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97699399">chr1:97699399</td>
                  <td id="rs72549307">rs72549307</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.632A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97699430">chr1:97699430</td>
                  <td id="rs72549308">rs72549308</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.601A&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97699474">chr1:97699474</td>
                  <td id="rs115232898">rs115232898</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.557A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97699506">chr1:97699506</td>
                  <td id="rs6670886">rs6670886</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.525G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97699533">chr1:97699533</td>
                  <td id="rs139834141">rs139834141</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.498G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97699535">chr1:97699535</td>
                  <td id="rs2297595">rs2297595</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.496A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97721542">chr1:97721542</td>
                  <td id="rs200562975">rs200562975</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.451A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97721650">chr1:97721650</td>
                  <td id="rs141462178">rs141462178</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.343A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97740400">chr1:97740400</td>
                  <td id="rs150385342">rs150385342</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.313G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97740410">chr1:97740410</td>
                  <td id="rs72549309">rs72549309</td>
                  
                  
                    <td class="">GATGA|GAT<br />GA</td>
                  
                  <td>
                    GATGA
                  </td>
                  <td>
                    c.295_298delTCAT (*7) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97883329">chr1:97883329</td>
                  <td id="rs1801265">rs1801265</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.85T&gt;C (*9A) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97883352">chr1:97883352</td>
                  <td id="rs80081766">rs80081766</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.62G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97883353">chr1:97883353</td>
                  <td id="rs72549310">rs72549310</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.61C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr1_97883368">chr1:97883368</td>
                  <td id="rs150036960">rs150036960</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.46C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene F5">
        <h3 id="F5">F5 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs6025 C/rs6025 C
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr1_169549811">chr1:169549811</td>
                  <td id="rs6025">rs6025</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    rs6025 T (Factor V Leiden) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene G6PD">
        <h3 id="G6PD">G6PD allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  B (reference)/B (reference)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning G6PD-hemizygous-samples">PharmCAT reports based on VCF file input and some VCF files do not specify hemizygous (one X chromosome) and instead represent samples as homozygous. See PharmCAT FAQs (https://pharmcat.org/faqs/).</div>
        
          <div class="alert alert-warning reference-allele">The G6PD B (reference) allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chrX_154532046">chrX:154532046</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Bangkok Noi 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532055">chrX:154532055</td>
                  <td id=""></td>
                  
                  
                    <td class="">CTCT|CTCT</td>
                  
                  <td>
                    CTCT
                  </td>
                  <td>
                    Brighton 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532082">chrX:154532082</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Arakawa 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532083">chrX:154532083</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Buenos Aires 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532085">chrX:154532085</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Campinas 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532086">chrX:154532086</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Fukaya 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532203">chrX:154532203</td>
                  <td id="rs137852348">rs137852348</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Split 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532231">chrX:154532231</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Laibin 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532245">chrX:154532245</td>
                  <td id="rs137852344">rs137852344</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Neapolis 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532257">chrX:154532257</td>
                  <td id="rs72554664">rs72554664</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Kaiping, Anant, Dhon, Sapporo-like, Wosera 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532258">chrX:154532258</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Flores Kamiube, Keelung 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532264">chrX:154532264</td>
                  <td id="rs782608284">rs782608284</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Yunan 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532265">chrX:154532265</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Nice 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532269">chrX:154532269</td>
                  <td id="rs72554665">rs72554665</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Bangkok Noi Canton, Taiwan-Hakka, Gifu-like, Agrigento-like Cosenza 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532278">chrX:154532278</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Amiens 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532279">chrX:154532279</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Figuera da Foz 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532389">chrX:154532389</td>
                  <td id="rs137852324">rs137852324</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Andalus 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532390">chrX:154532390</td>
                  <td id="rs398123546">rs398123546</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Hermoupolis Honiara Union,Maewo, Chinese-2, Kalo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532392">chrX:154532392</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Harima 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532403">chrX:154532403</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Cassano Hermoupolis 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532408">chrX:154532408</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    S. Antioco 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532411">chrX:154532411</td>
                  <td id="rs137852317">rs137852317</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Santiago de Cuba, Morioka 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532432">chrX:154532432</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Telti/Kobe 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532434">chrX:154532434</td>
                  <td id="rs137852337">rs137852337</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Pawnee 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532458">chrX:154532458</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Sumare 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532459">chrX:154532459</td>
                  <td id="rs782098548">rs782098548</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Surabaya 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532570">chrX:154532570</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Georgia 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532590">chrX:154532590</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    202G&gt;A_376A&gt;G_1264C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532608">chrX:154532608</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Tokyo, Fukushima 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532623">chrX:154532623</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Munich 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532625">chrX:154532625</td>
                  <td id="rs137852336">rs137852336</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Japan, Shinagawa Kawasaki 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532626">chrX:154532626</td>
                  <td id="rs137852323">rs137852323</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Riverside 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532628">chrX:154532628</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Suwalki 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532629">chrX:154532629</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Utrecht 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532634">chrX:154532634</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Abeno 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532639">chrX:154532639</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Clinic 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532649">chrX:154532649</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Covao do Lobo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532661">chrX:154532661</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Anadia 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532662">chrX:154532662</td>
                  <td id="rs137852325">rs137852325</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Puerto Limon 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532667">chrX:154532667</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Bari 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532674">chrX:154532674</td>
                  <td id="rs137852335">rs137852335</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Alhambra 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532676">chrX:154532676</td>
                  <td id="rs137852316">rs137852316</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Nashville, Anaheim, Portici 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532677">chrX:154532677</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Wisconsin 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532679">chrX:154532679</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Krakow 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532688">chrX:154532688</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Praha 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532692">chrX:154532692</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Hartford 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532694">chrX:154532694</td>
                  <td id="rs137852321">rs137852321</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Beverly Hills, Genova, Iwate, Niigata, Yamaguchi 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532695">chrX:154532695</td>
                  <td id="rs137852334">rs137852334</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Guadalajara Mt Sinai 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532698">chrX:154532698</td>
                  <td id="rs137852320">rs137852320</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Iowa, Walter Reed, Springfield 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532699">chrX:154532699</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Madrid 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532700">chrX:154532700</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Lynwood 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532701">chrX:154532701</td>
                  <td id="rs137852322">rs137852322</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Tomah 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532713">chrX:154532713</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Olomouc 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532715">chrX:154532715</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Riley 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532716">chrX:154532716</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Calvo Mackenna 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532722">chrX:154532722</td>
                  <td id="rs371489738">rs371489738</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Montpellier 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532752">chrX:154532752</td>
                  <td id=""></td>
                  
                  
                    <td class="">CGGCCTTGC<br />GCTCGTTCA<br />G|CGGCCTT<br />GCGCTCGTT<br />CAG</td>
                  
                  <td>
                    CGGCCTTGC<br />GCTCGTTCA<br />G
                  </td>
                  <td>
                    Tondela 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532758">chrX:154532758</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Tenri 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532765">chrX:154532765</td>
                  <td id="rs137852329">rs137852329</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Aachen Loma Linda 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532772">chrX:154532772</td>
                  <td id="rs137852345">rs137852345</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Serres 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532773">chrX:154532773</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Iwatsuki 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532797">chrX:154532797</td>
                  <td id="rs137852333">rs137852333</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Ierapetra 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532802">chrX:154532802</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Partenope 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532945">chrX:154532945</td>
                  <td id="rs34193178">rs34193178</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Mira d&#x27;Aire 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532956">chrX:154532956</td>
                  <td id="rs398123544">rs398123544</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Cincinnati 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532969">chrX:154532969</td>
                  <td id="rs137852342">rs137852342</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Chinese-5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532987">chrX:154532987</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Torun 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532989">chrX:154532989</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Fushan 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154532990">chrX:154532990</td>
                  <td id="rs5030869">rs5030869</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Chatham 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533004">chrX:154533004</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Insuli 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533012">chrX:154533012</td>
                  <td id=""></td>
                  
                  
                    <td class="">CGTGGGGTC<br />GTCCAGGTA<br />CCCTTTG|C<br />GTGGGGTCG<br />TCCAGGTAC<br />CCTTTG</td>
                  
                  <td>
                    CGTGGGGTC<br />GTCCAGGTA<br />CCCTTTG
                  </td>
                  <td>
                    Nara 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533016">chrX:154533016</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Farroupilha 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533025">chrX:154533025</td>
                  <td id="rs76723693">rs76723693</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    A- 968C_376G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533029">chrX:154533029</td>
                  <td id="rs137852347">rs137852347</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Rehevot 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533031">chrX:154533031</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Manhattan 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533044">chrX:154533044</td>
                  <td id="rs137852339">rs137852339</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Kalyan-Kerala, Jamnaga, Rohini 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533064">chrX:154533064</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Ludhiana 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533072">chrX:154533072</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Omiya 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533077">chrX:154533077</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Seoul 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533083">chrX:154533083</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    West Virginia 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533122">chrX:154533122</td>
                  <td id="rs137852327">rs137852327</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Ananindeua Hechi Viangchan, Jammu 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533586">chrX:154533586</td>
                  <td id="rs74575103">rs74575103</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Montalbano 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533587">chrX:154533587</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Osaka 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533589">chrX:154533589</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Piotrkow 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533591">chrX:154533591</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Papua 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533592">chrX:154533592</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Mizushima 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533596">chrX:154533596</td>
                  <td id="rs137852318">rs137852318</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Bajo Maumere Seattle, Lodi, Modena, Ferrara II, Athens-like 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533605">chrX:154533605</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Chinese-1 Haikou 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533607">chrX:154533607</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Wexham 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533608">chrX:154533608</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    La Jolla 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533614">chrX:154533614</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Sugao 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533615">chrX:154533615</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Bangkok 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533619">chrX:154533619</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Lille 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533620">chrX:154533620</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Cleveland Corum 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533629">chrX:154533629</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Roubaix 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154533634">chrX:154533634</td>
                  <td id="rs137852346">rs137852346</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Aveiro 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534036">chrX:154534036</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Wayne 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534074">chrX:154534074</td>
                  <td id=""></td>
                  
                  
                    <td class="">TCAGTGC|T<br />CAGTGC</td>
                  
                  <td>
                    TCAGTGC
                  </td>
                  <td>
                    Stonybrook 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534092">chrX:154534092</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Durham 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534102">chrX:154534102</td>
                  <td id="rs782757170">rs782757170</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Nanning 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534110">chrX:154534110</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Asahikawa 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534116">chrX:154534116</td>
                  <td id=""></td>
                  
                  
                    <td class="">ATGT|ATGT</td>
                  
                  <td>
                    ATGT
                  </td>
                  <td>
                    North Dallas 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534125">chrX:154534125</td>
                  <td id="rs137852328">rs137852328</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    A- 680T_376G Mexico City 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534126">chrX:154534126</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Radlowo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534157">chrX:154534157</td>
                  <td id="rs137852319">rs137852319</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Harilaou 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534345">chrX:154534345</td>
                  <td id="rs137852326">rs137852326</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Cincinnati Minnesota, Marion, Gastonia, LeJeune 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534348">chrX:154534348</td>
                  <td id="rs782754619">rs782754619</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Sibari 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534387">chrX:154534387</td>
                  <td id="rs781865768">rs781865768</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Dagua 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534389">chrX:154534389</td>
                  <td id="rs137852332">rs137852332</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Nilgiri Santiago 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534390">chrX:154534390</td>
                  <td id="rs137852330">rs137852330</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Coimbra Shunde Vancouver 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534409">chrX:154534409</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Pedoplis-Ckaro 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534414">chrX:154534414</td>
                  <td id=""></td>
                  
                  
                    <td class="">GGGA|GGGA</td>
                  
                  <td>
                    GGGA
                  </td>
                  <td>
                    Tsukui 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534419">chrX:154534419</td>
                  <td id="rs5030868">rs5030868</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534438">chrX:154534438</td>
                  <td id="rs267606836">rs267606836</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Vancouver 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534440">chrX:154534440</td>
                  <td id="rs5030872">rs5030872</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Malaga Santa Maria 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534447">chrX:154534447</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Chikugo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534455">chrX:154534455</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Shinshu 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534463">chrX:154534463</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Miaoli 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534465">chrX:154534465</td>
                  <td id="rs137852343">rs137852343</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Nankang 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534468">chrX:154534468</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Volendam 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534485">chrX:154534485</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Naone 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534486">chrX:154534486</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Toledo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534489">chrX:154534489</td>
                  <td id="rs137852331">rs137852331</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Taipei, Chinese-3 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534494">chrX:154534494</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Plymouth 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154534495">chrX:154534495</td>
                  <td id="rs137852314">rs137852314</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Mahidol 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535176">chrX:154535176</td>
                  <td id="rs370918918">rs370918918</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Gond 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535180">chrX:154535180</td>
                  <td id="rs782487723">rs782487723</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Shenzen 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535187">chrX:154535187</td>
                  <td id="rs137852313">rs137852313</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Ilesha 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535190">chrX:154535190</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Acrokorinthos 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535211">chrX:154535211</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Liuzhou 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535244">chrX:154535244</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Belem 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535247">chrX:154535247</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Valladolid 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535249">chrX:154535249</td>
                  <td id="rs782322505">rs782322505</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Cairo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535261">chrX:154535261</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Quing Yan 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535269">chrX:154535269</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Crispim 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535270">chrX:154535270</td>
                  <td id="rs78365220">rs78365220</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Crispim Salerno Pyrgos Vanua Lava 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535274">chrX:154535274</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Crispim 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535277">chrX:154535277</td>
                  <td id="rs1050829">rs1050829</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    202G&gt;A_376A&gt;G_1264C&gt;G A A- 202A_376G A- 680T_376G A- 968C_376G Acrokorinthos Ananindeua Mt Sinai Santa Maria Sierra Leone 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535278">chrX:154535278</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Crispim 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535301">chrX:154535301</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Bao Loc 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535316">chrX:154535316</td>
                  <td id="rs5030870">rs5030870</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Sao Borja 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535330">chrX:154535330</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Hammersmith 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535336">chrX:154535336</td>
                  <td id="rs267606835">rs267606835</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Vancouver 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535342">chrX:154535342</td>
                  <td id="rs181277621">rs181277621</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Sierra Leone 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535367">chrX:154535367</td>
                  <td id=""></td>
                  
                  
                    <td class="">GCTT|GCTT</td>
                  
                  <td>
                    GCTT
                  </td>
                  <td>
                    Urayasu 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535379">chrX:154535379</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Guangzhou 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535962">chrX:154535962</td>
                  <td id="rs782308266">rs782308266</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Lagosanto 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535963">chrX:154535963</td>
                  <td id="rs138687036">rs138687036</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Ube Konan 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535980">chrX:154535980</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Swansea 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535995">chrX:154535995</td>
                  <td id="rs782090947">rs782090947</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Murcia Oristano 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154535996">chrX:154535996</td>
                  <td id="rs137852349">rs137852349</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Namouru 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536002">chrX:154536002</td>
                  <td id="rs1050828">rs1050828</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    202G&gt;A_376A&gt;G_1264C&gt;G A- 202A_376G Asahi Hechi 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536008">chrX:154536008</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Songklanagarind 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536019">chrX:154536019</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Amazonia Musashino 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536021">chrX:154536021</td>
                  <td id=""></td>
                  
                  
                    <td class="">CAGA|CAGA</td>
                  
                  <td>
                    CAGA
                  </td>
                  <td>
                    Amsterdam 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536025">chrX:154536025</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Costanzo 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536032">chrX:154536032</td>
                  <td id="rs137852315">rs137852315</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Metaponto 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536034">chrX:154536034</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Palestrina 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536035">chrX:154536035</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Kamogawa 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536045">chrX:154536045</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Kozukata 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536151">chrX:154536151</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Kambos 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536156">chrX:154536156</td>
                  <td id="rs76645461">rs76645461</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Aures 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536168">chrX:154536168</td>
                  <td id="rs78478128">rs78478128</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    Orissa 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154536169">chrX:154536169</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Rignano 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546045">chrX:154546045</td>
                  <td id="rs137852338">rs137852338</td>
                  
                  
                    <td class="">CATG|CATG</td>
                  
                  <td>
                    CATG
                  </td>
                  <td>
                    Sunderland 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546046">chrX:154546046</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    Gidra 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546057">chrX:154546057</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Honiara 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546061">chrX:154546061</td>
                  <td id="rs137852340">rs137852340</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    Gaohe 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546116">chrX:154546116</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Lages 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546122">chrX:154546122</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    Sinnai 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chrX_154546131">chrX:154546131</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    No name 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene IFNL3/4">
        <h3 id="IFNL3/4">IFNL3/4 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs12979860 reference (C)/rs12979860 reference (C)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr19_39248147">chr19:39248147</td>
                  <td id="rs12979860">rs12979860</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    rs12979860 variant (T) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene NUDT15">
        <h3 id="NUDT15">NUDT15 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The NUDT15 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr13_48037748">chr13:48037748</td>
                  <td id="rs769369441">rs769369441</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037749">chr13:48037749</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *19 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037782">chr13:48037782</td>
                  <td id="rs746071566">rs746071566</td>
                  
                  
                    <td class="">AGGAGTC|A<br />GGAGTC</td>
                  
                  <td>
                    AGGAGTC
                  </td>
                  <td>
                    *2 *6 *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037798">chr13:48037798</td>
                  <td id="rs186364861">rs186364861</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037825">chr13:48037825</td>
                  <td id="rs777311140">rs777311140</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *14 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037834">chr13:48037834</td>
                  <td id="rs1202487323">rs1202487323</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *16 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037847">chr13:48037847</td>
                  <td id="rs766023281">rs766023281</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037849">chr13:48037849</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037885">chr13:48037885</td>
                  <td id="rs1950545307">rs1950545307</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *11 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48037902">chr13:48037902</td>
                  <td id="rs149436418">rs149436418</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48040977">chr13:48040977</td>
                  <td id="rs1457579126">rs1457579126</td>
                  
                  
                    <td class="">GA|GA</td>
                  
                  <td>
                    GA
                  </td>
                  <td>
                    *18 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48041103">chr13:48041103</td>
                  <td id="rs761191455">rs761191455</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48041113">chr13:48041113</td>
                  <td id="rs1368252918">rs1368252918</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48045690">chr13:48045690</td>
                  <td id="rs768324690">rs768324690</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *20 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48045719">chr13:48045719</td>
                  <td id="rs116855232">rs116855232</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *2 *3 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48045720">chr13:48045720</td>
                  <td id="rs147390019">rs147390019</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr13_48045771">chr13:48045771</td>
                  <td id="rs139551410">rs139551410</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *15 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene RYR1">
        <h3 id="RYR1">RYR1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  No CPIC variants found
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The RYR1 Reference allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr19_38440802">chr19:38440802</td>
                  <td id="rs193922747">rs193922747</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.103T&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38440829">chr19:38440829</td>
                  <td id="rs193922748">rs193922748</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.130C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38444211">chr19:38444211</td>
                  <td id="rs118192161">rs118192161</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.487C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38444212">chr19:38444212</td>
                  <td id="rs193922753">rs193922753</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.488G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38446710">chr19:38446710</td>
                  <td id="rs1801086">rs1801086</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.742G&gt;A c.742G&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38448673">chr19:38448673</td>
                  <td id="rs193922762">rs193922762</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.982C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38448712">chr19:38448712</td>
                  <td id="rs121918592">rs121918592</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1021G&gt;A c.1021G&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38451842">chr19:38451842</td>
                  <td id="rs193922764">rs193922764</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1201C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38451850">chr19:38451850</td>
                  <td id="rs118192116">rs118192116</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1209C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38455359">chr19:38455359</td>
                  <td id="rs118192162">rs118192162</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.1565A&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38455463">chr19:38455463</td>
                  <td id="rs111888148">rs111888148</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1589G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38455471">chr19:38455471</td>
                  <td id="rs193922768">rs193922768</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1597C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38455472">chr19:38455472</td>
                  <td id="rs144336148">rs144336148</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1598G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38455528">chr19:38455528</td>
                  <td id="rs193922770">rs193922770</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1654C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38457545">chr19:38457545</td>
                  <td id="rs118192172">rs118192172</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.1840C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38457546">chr19:38457546</td>
                  <td id="rs193922772">rs193922772</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.1841G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38494564">chr19:38494564</td>
                  <td id="rs118192175">rs118192175</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.6487C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38494565">chr19:38494565</td>
                  <td id="rs118192163">rs118192163</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.6488G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38494579">chr19:38494579</td>
                  <td id="rs118192176">rs118192176</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.6502G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38496283">chr19:38496283</td>
                  <td id="rs118192177">rs118192177</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.6617C&gt;G c.6617C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499223">chr19:38499223</td>
                  <td id="rs112563513">rs112563513</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7007G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499644">chr19:38499644</td>
                  <td id="rs121918596">rs121918596</td>
                  
                  
                    <td class="">TGGA|TGGA</td>
                  
                  <td>
                    TGGA
                  </td>
                  <td>
                    c.7042_7044delGAG 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499655">chr19:38499655</td>
                  <td id="rs193922802">rs193922802</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7048G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499670">chr19:38499670</td>
                  <td id="rs193922803">rs193922803</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.7063C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499731">chr19:38499731</td>
                  <td id="rs193922807">rs193922807</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7124G&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499975">chr19:38499975</td>
                  <td id="rs193922809">rs193922809</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7282G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499993">chr19:38499993</td>
                  <td id="rs121918593">rs121918593</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7300G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38499997">chr19:38499997</td>
                  <td id="rs28933396">rs28933396</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7304G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500636">chr19:38500636</td>
                  <td id="rs118192124">rs118192124</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.7354C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500642">chr19:38500642</td>
                  <td id="rs193922816">rs193922816</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.7360C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500643">chr19:38500643</td>
                  <td id="rs118192122">rs118192122</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7361G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500654">chr19:38500654</td>
                  <td id="rs28933397">rs28933397</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.7372C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500655">chr19:38500655</td>
                  <td id="rs121918594">rs121918594</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7373G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500898">chr19:38500898</td>
                  <td id="rs118192178">rs118192178</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.7522C&gt;G c.7522C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38500899">chr19:38500899</td>
                  <td id="rs193922818">rs193922818</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.7523G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38512321">chr19:38512321</td>
                  <td id="rs193922832">rs193922832</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.9310G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38543832">chr19:38543832</td>
                  <td id="rs193922843">rs193922843</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.11969G&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38580004">chr19:38580004</td>
                  <td id="rs118192167">rs118192167</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    c.14387A&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38580094">chr19:38580094</td>
                  <td id="rs121918595">rs121918595</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.14477C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38580114">chr19:38580114</td>
                  <td id="rs193922876">rs193922876</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.14497C&gt;T 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38580370">chr19:38580370</td>
                  <td id="rs193922878">rs193922878</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    c.14512C&gt;G 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38580403">chr19:38580403</td>
                  <td id="rs118192168">rs118192168</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.14545G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38580440">chr19:38580440</td>
                  <td id="rs63749869">rs63749869</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    c.14582G&gt;A 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr19_38584989">chr19:38584989</td>
                  <td id="rs118192170">rs118192170</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    c.14693T&gt;C 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene SLCO1B1">
        <h3 id="SLCO1B1">SLCO1B1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *37/*37
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning SLCO1B1-drug-text">The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.<br><br>In case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr12_21172734">chr12:21172734</td>
                  <td id="rs139257324">rs139257324</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *33 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21172776">chr12:21172776</td>
                  <td id="rs373327528">rs373327528</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *23 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21172782">chr12:21172782</td>
                  <td id="rs56101265">rs56101265</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *2 *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21174595">chr12:21174595</td>
                  <td id="rs56061388">rs56061388</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *3 *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21176804">chr12:21176804</td>
                  <td id="rs2306283">rs2306283</td>
                  
                  
                    <td class="nonwild">G/G</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *14 *15 *20 *24 *25 *27 *28 *29 *30 *31 *32 *33 *37 *39 *42 *43 *44 *46 *47 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21176868">chr12:21176868</td>
                  <td id="rs2306282">rs2306282</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *16 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21176871">chr12:21176871</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *38 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21176879">chr12:21176879</td>
                  <td id="rs11045819">rs11045819</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *4 *14 *25 *32 *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21176883">chr12:21176883</td>
                  <td id="rs72559745">rs72559745</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *3 *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21176898">chr12:21176898</td>
                  <td id="rs77271279">rs77271279</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *41 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21178612">chr12:21178612</td>
                  <td id="rs141467543">rs141467543</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *42 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21178615">chr12:21178615</td>
                  <td id="rs4149056">rs4149056</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *5 *15 *40 *46 *47 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21178957">chr12:21178957</td>
                  <td id="rs79135870">rs79135870</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *30 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21196951">chr12:21196951</td>
                  <td id="rs11045852">rs11045852</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *24 *25 *28 *32 *33 *43 *44 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21196975">chr12:21196975</td>
                  <td id="rs183501729">rs183501729</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21196976">chr12:21196976</td>
                  <td id="rs11045853">rs11045853</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *25 *28 *33 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21200544">chr12:21200544</td>
                  <td id="rs72559747">rs72559747</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *47 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21200595">chr12:21200595</td>
                  <td id="rs55901008">rs55901008</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21202553">chr12:21202553</td>
                  <td id="rs1228465562">rs1228465562</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *36 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21202555">chr12:21202555</td>
                  <td id="rs59113707">rs59113707</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *27 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21202649">chr12:21202649</td>
                  <td id="rs56387224">rs56387224</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21202664">chr12:21202664</td>
                  <td id="rs142965323">rs142965323</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *26 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21205921">chr12:21205921</td>
                  <td id="rs72559748">rs72559748</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21205999">chr12:21205999</td>
                  <td id="rs59502379">rs59502379</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *9 *31 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21206031">chr12:21206031</td>
                  <td id="rs74064213">rs74064213</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *43 *44 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21222355">chr12:21222355</td>
                  <td id="rs71581941">rs71581941</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *45 *46 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21239042">chr12:21239042</td>
                  <td id="rs34671512">rs34671512</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *19 *20 *40 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21239077">chr12:21239077</td>
                  <td id="rs56199088">rs56199088</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *10 *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21239113">chr12:21239113</td>
                  <td id="rs55737008">rs55737008</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *11 *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21239145">chr12:21239145</td>
                  <td id="rs200995543">rs200995543</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr12_21239158">chr12:21239158</td>
                  <td id="rs140790673">rs140790673</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *29 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene TPMT">
        <h3 id="TPMT">TPMT allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*1
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Phased
                  </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The TPMT *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr6_18130687">chr6:18130687</td>
                  <td id="rs1142345">rs1142345</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *3A *3C *41 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130694">chr6:18130694</td>
                  <td id="rs150900439">rs150900439</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *20 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130725">chr6:18130725</td>
                  <td id="rs72552736">rs72552736</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *7 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130729">chr6:18130729</td>
                  <td id="rs139392616">rs139392616</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *40 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130758">chr6:18130758</td>
                  <td id="rs398122996">rs398122996</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *37 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130762">chr6:18130762</td>
                  <td id="rs56161402">rs56161402</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *8 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130772">chr6:18130772</td>
                  <td id="rs377085266">rs377085266</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *25 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18130781">chr6:18130781</td>
                  <td id="rs1800584">rs1800584</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *4 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18132136">chr6:18132136</td>
                  <td id="rs72556347">rs72556347</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *26 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18132147">chr6:18132147</td>
                  <td id="rs79901429">rs79901429</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *31 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18132163">chr6:18132163</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *36 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18133845">chr6:18133845</td>
                  <td id="rs75543815">rs75543815</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18133847">chr6:18133847</td>
                  <td id="rs6921269">rs6921269</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *24 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18133870">chr6:18133870</td>
                  <td id="rs772832951">rs772832951</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *38 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18133884">chr6:18133884</td>
                  <td id="rs74423290">rs74423290</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *23 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18133887">chr6:18133887</td>
                  <td id="rs201695576">rs201695576</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *44 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18133890">chr6:18133890</td>
                  <td id="rs9333570">rs9333570</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *15 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18138969">chr6:18138969</td>
                  <td id="rs144041067">rs144041067</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *16 *22 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18138970">chr6:18138970</td>
                  <td id="rs112339338">rs112339338</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *33 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18138997">chr6:18138997</td>
                  <td id="rs1800460">rs1800460</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *3A *3B 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18139027">chr6:18139027</td>
                  <td id="rs72552737">rs72552737</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *10 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18139689">chr6:18139689</td>
                  <td id="rs72552738">rs72552738</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *11 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18139710">chr6:18139710</td>
                  <td id="rs200220210">rs200220210</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *12 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143597">chr6:18143597</td>
                  <td id=""></td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *19 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143606">chr6:18143606</td>
                  <td id="rs151149760">rs151149760</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *9 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143613">chr6:18143613</td>
                  <td id=""></td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *28 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143622">chr6:18143622</td>
                  <td id="rs115106679">rs115106679</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *32 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143643">chr6:18143643</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *27 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143700">chr6:18143700</td>
                  <td id="rs753545734">rs753545734</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143718">chr6:18143718</td>
                  <td id="rs111901354">rs111901354</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *34 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143724">chr6:18143724</td>
                  <td id="rs1800462">rs1800462</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *2 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18143728">chr6:18143728</td>
                  <td id="rs1256618794">rs1256618794</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *43 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18147838">chr6:18147838</td>
                  <td id="rs281874771">rs281874771</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *39 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18147845">chr6:18147845</td>
                  <td id="rs777686348">rs777686348</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *18 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18147851">chr6:18147851</td>
                  <td id="rs200591577">rs200591577</td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *21 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18147856">chr6:18147856</td>
                  <td id=""></td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *35 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18147910">chr6:18147910</td>
                  <td id="rs72552740">rs72552740</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *5 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18149004">chr6:18149004</td>
                  <td id=""></td>
                  
                  
                    <td class="">G|G</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *17 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18149022">chr6:18149022</td>
                  <td id="rs750424422">rs750424422</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *30 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18149032">chr6:18149032</td>
                  <td id="rs759836180">rs759836180</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *42 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18149045">chr6:18149045</td>
                  <td id="rs72552742">rs72552742</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *13 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18149126">chr6:18149126</td>
                  <td id="rs267607275">rs267607275</td>
                  
                  
                    <td class="">A|A</td>
                  
                  <td>
                    A
                  </td>
                  <td>
                    *29 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr6_18149127">chr6:18149127</td>
                  <td id="rs9333569">rs9333569</td>
                  
                  
                    <td class="">T|T</td>
                  
                  <td>
                    T
                  </td>
                  <td>
                    *14 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene UGT1A1">
        <h3 id="UGT1A1">UGT1A1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  *1/*6
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        
          <div class="alert alert-warning reference-allele">The UGT1A1 *1 allele assignment is characterized by the absence of variants at the positions that are included in the underlying allele definitions.</div>
        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr2_233759924">chr2:233759924</td>
                  <td id="rs887829">rs887829</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *80 *80+*28 *80+*37 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr2_233760233">chr2:233760233</td>
                  <td id="rs3064744">rs3064744</td>
                  
                  
                    <td class="">CAT|CAT</td>
                  
                  <td>
                    CAT
                  </td>
                  <td>
                    *28 *36 *37 *80+*28 *80+*37 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr2_233760498">chr2:233760498</td>
                  <td id="rs4148323">rs4148323</td>
                  
                  
                    <td class="nonwild">G/A</td>
                  
                  <td>
                    G
                  </td>
                  <td>
                    *6 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
                <tr>
                  <td id="chr2_233760973">chr2:233760973</td>
                  <td id="rs35350960">rs35350960</td>
                  
                  
                    <td class="">C|C</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    *27 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    
      <section class="gene VKORC1">
        <h3 id="VKORC1">VKORC1 allele match data</h3>

        
          <table>
            <tbody>
            <tr>
              <th style="width: 12em;">Genotype Matched:</th>
              <td class="top-aligned genotype-result">
                
                  rs9923231 variant (T)/rs9923231 variant (T)
                

                
              </td>
            </tr>
            
              <tr>
                <th>Phasing Status:</th>
                <td class="top-aligned">
                  <p>
                    Unphased
                  </p>
                  
                    <p>
                      PharmCAT reports the genotype(s) that receive the highest score during the matcher process. In
                      case of unphased data, additional genotypes might be possible and cannot be ruled out.
                    </p>
                  
                </td>
              </tr>
            
            
            </tbody>
          </table>
        

        

        
          
            <h4>Calls at Positions</h4>
            <table>
              <thead>
              <tr>
                <th>Position in VCF</th>
                <th>RSID</th>
                <th>Call in VCF</th>
                <th>Reference</th>
                <th>Related Alleles</th>
                <th>Warnings</th>
              </tr>
              </thead>
              <tbody>
              
                <tr>
                  <td id="chr16_31096368">chr16:31096368</td>
                  <td id="rs9923231">rs9923231</td>
                  
                  
                    <td class="nonwild">T/T</td>
                  
                  <td>
                    C
                  </td>
                  <td>
                    rs9923231 variant (T) 
                  </td>
                  <td>
                    <ul class="warningList">
                      
                    </ul>
                  </td>
                </tr>
              
              </tbody>
            </table>
          

          

        

      </section>
    

  </section>

  <section id="disclaimer">
<h2 id="disclaimers-and-other-information">Disclaimers and Other Information</h2>
<p><strong>Liability: PharmCAT assumes no responsibility for any injury to person or damage to persons or property arising out of,
or related to any use of PharmCAT, or for any errors or omissions. The user recognizes that PharmCAT is a research tool
and that they are using PharmCAT at their own risk.</strong></p>
<h3 id="a-allele-and-genotype-determination">A. Allele and Genotype Determination</h3>
<ol>
<li><p>PharmCAT uses gene allele definitions included in the CPIC database, with exceptions as noted
in <a href="https://pharmcat.org/methods/Gene-Definition-Exceptions/">Gene Definition Exceptions document</a>. For allele
definitions and the positions used in PharmCAT, see
the <a href="https://github.com/PharmGKB/PharmCAT/releases">gene definition tables</a>.</p></li>
<li><p>Genes with DPWG recommendations that are not included in CPIC are discussed in Section C.   </p></li>
<li><p>PharmCAT results are dependent on the supplied VCF calls for the queried positions (for technical information about
PharmCAT input formatting and requirements, please go to <a href="https://pharmcat.org/">pharmcat.org</a>). PharmCAT does not
assume any reference calls for positions missing from the submitted VCF file; all missing queried positions are not
considered in the allele determination process. See the
<a href="https://github.com/PharmGKB/PharmCAT/releases"><em>pharmcat_positions</em> file</a> for which positions are
queried in the VCF file. Missing positions might alter the assigned genotype and subsequent phenotype prediction and
CPIC recommendation. If the supplied VCF file has missing positions, those positions will be noted in
Section III: Allele Matching Details for each gene of this report. For the most reliable allele determination,
reference calls as well as variant calls in the VCF file for every queried position must be provided by the user.
If an allele that includes a missing position is defined by an additional position(s) for which calls are provided,
the allele will be considered in the matching process based on the available information. This might lead to the output
of multiple possible genotypes that received the same highest matching score. In addition, alternate calls with a lower
score is also possible. For instructions on getting PharmCAT to output all possible matching genotypes, consult
<a href="https://pharmcat.org/using/Running-PharmCAT/#named-allele-matcher">the documentation</a>.</p></li>
<li><p>For cytochrome P450 genes, TPMT, NUDT15, UGT1A1, and SLCO1B1, the *1 allele is defined by the absence of variation
specified in the gene definition tables. This allele cannot be identified by variants; rather, *1 is assigned by
default when no variation for the queried positions is reported in the submitted VCF file. The same is true for all
other genes with multiple variant positions in the definition table (CACNA1S, CFTR, DPYD, RYR1): the reference
sequence is the default result when variants are not reported in the VCF file. It is always possible un-interrogated
variation can occur which could potentially affect allele function, but because it is undetected, the assignment
would be defaulted to a *1 (or reference) allele and normal function.</p></li>
<li><p>For all genes, variation reported in the VCF file but NOT included in the gene definition table will not be
considered during allele assignment. There is a possibility that any such variation results in a reduced or no
activity allele which could lead to inaccurate phenotype and CPIC recommendation, similar to the situation in point
3, above.</p></li>
<li><p>Nucleotide base calls are displayed on the positive chromosomal strand regardless of the gene strand; further
information is provided under Gene-specific warnings in Section III: Allele Matching Details.</p></li>
<li><p>PharmCAT matches variants to genotypes assuming unphased data (unless phased data is provided in the VCF file and
noted as such, see <a href="https://pharmcat.org/">pharmcat.org</a> for details). The assumption is that defined alleles exist
in trans configuration, i.e. on opposite chromosomes, with exceptions noted in Section III: Allele Matching Details
under "Gene-specific warnings." However, in cases where an allele is defined by a combination of two or more
variants, where each variant alone also defines an allele, the match is based on the longer allele. For example,
TPMT*3B is defined by one SNP, *3C is defined by another SNP, and *3A is defined by the combination of those two
SNPs. In the case of unphased data that is heterozygous for both SNPs, the *1/*3A genotype is returned though the
possibility of *3B/*3C cannot be ruled out.</p>
<p>Below cases are summarized for which two calls with different scores are possible when provided unphased data and
heterozygous calls for the variants that define the two alleles. The genotype with the higher score (longer allele)
will be used to determine allele functionality, phenotype, and recommendation but the genotype with the lower score
cannot be ruled out.</p></li>
</ol>
<p>Table 1: Cases for which there is an overlap in the allele definitions.</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Genotype (Higher Score)</th>
<th>Phenotype</th>
<th>Genotype (Lower Score)</th>
<th>Phenotype</th>
</tr>
</thead>
<tbody>
<tr>
<td>UGT1A1</td>
<td>*1/*80+*28</td>
<td>Intermediate</td>
<td>*28/*80</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>UGT1A1</td>
<td>*1/*80+*37</td>
<td>Intermediate</td>
<td>*37/*80</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>TPMT</td>
<td>*1/*3A</td>
<td>Intermediate</td>
<td>*3B/*3C</td>
<td>Poor</td>
</tr>
<tr>
<td>NUDT15</td>
<td>*1/*2</td>
<td>Intermediate</td>
<td>*3/*6</td>
<td>Possible Intermediate</td>
</tr>
<tr>
<td>CYP2C9</td>
<td>*1/*71</td>
<td>N/A</td>
<td>*10/*22</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*36</td>
<td>Intermediate</td>
<td>*6/*22</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*34</td>
<td>Intermediate</td>
<td>*33/*36</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*6</td>
<td>Intermediate</td>
<td>*4/*9</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*7</td>
<td>Intermediate</td>
<td>*5/*6</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*13</td>
<td>Intermediate</td>
<td>*6/*8</td>
<td>Intermediate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*46</td>
<td>Decreased function</td>
<td>*15/*45</td>
<td>Possible Decreased Function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*20</td>
<td>Normal Function</td>
<td>*19/*37</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*12</td>
<td>Indeterminate</td>
<td>*2/*10</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*13</td>
<td>Indeterminate</td>
<td>*3/*11</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*14</td>
<td>Normal Function</td>
<td>*4/*37</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*15</td>
<td>Decreased function</td>
<td>*5/*37</td>
<td>Decreased function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*25</td>
<td>Indeterminate</td>
<td>*4/*28</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*31</td>
<td>Decreased function</td>
<td>*9/*37</td>
<td>Decreased Function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*32</td>
<td>Indeterminate</td>
<td>*4/*24</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*40</td>
<td>Indeterminate</td>
<td>*5/*19</td>
<td>Possible Decreased Function</td>
</tr>
<tr>
<td>SLCO1B1</td>
<td>*1/*43</td>
<td>Indeterminate</td>
<td>*4/*44</td>
<td>Indeterminate</td>
</tr>
<tr>
<td>CYP4F2</td>
<td>*1/*4</td>
<td>N/A</td>
<td>*2/*3</td>
<td>N/A</td>
</tr>
<tr>
<td>CYP3A4</td>
<td>*1/*37</td>
<td>N/A</td>
<td>*3/*22</td>
<td>N/A</td>
</tr>
<tr>
<td>CYP3A4</td>
<td>*1/*38</td>
<td>N/A</td>
<td>*3/*11</td>
<td>N/A</td>
</tr>
<tr>
<td>G6PD</td>
<td>A- 202A_376G/B (reference)</td>
<td>Variable</td>
<td>A/Asahi</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Mt Sinai</td>
<td>Variable</td>
<td>A/Guadalajara</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Santa Maria</td>
<td>Variable</td>
<td>A/Malaga</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>Ananindeua/B (reference)</td>
<td>Variable</td>
<td>A/Viangchan, Jammu</td>
<td>Variable</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Hechi</td>
<td>Variable</td>
<td>Asahi/Viangchan, Jammu</td>
<td>Deficient</td>
</tr>
<tr>
<td>G6PD</td>
<td>B (reference)/Hermoupolis</td>
<td>Variable</td>
<td>Cassano/Union,Maewo, Chinese-2, Kalo</td>
<td>Deficient</td>
</tr>
</tbody>
</table>
<p>Table 2: Cases for which there is an overlap in the allele definitions because the definition of the non-*1 allele in
the genotype with the higher score allows for reference or variant at the position that defines the first allele listed
in the genotype with the lower score. Both genotypes cannot be ruled out with unphased data if the position that
overlaps between the respective alleles is heterozygous (0/1) in addition to heterozygous calls for the other variants
that define the non-*1 allele in the genotype with the higher score.</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Genotype (Higher Score)</th>
<th>Phenotype</th>
<th>Genotype (Lower Score)</th>
<th>Phenotype</th>
</tr>
</thead>
<tbody>
<tr>
<td>CYP2C19</td>
<td>*1/*4</td>
<td>Intermediate</td>
<td>*17/*4</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2C19</td>
<td>*1/*2</td>
<td>Intermediate</td>
<td>*11/*2</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2C19</td>
<td>*1/*35</td>
<td>Intermediate</td>
<td>*15/*35</td>
<td>Intermediate</td>
</tr>
<tr>
<td>CYP2B6</td>
<td>*1/*18</td>
<td>Intermediate</td>
<td>*4/*18</td>
<td>Indeterminate</td>
</tr>
</tbody>
</table>
<h3 id="b-cpic-allele-function-phenotype-and-recommendation">B. CPIC Allele Function, Phenotype and Recommendation</h3>
<p>All content is sourced from the <a href="https://github.com/cpicpgx/cpic-data">CPIC database</a>.</p>
<h3 id="c-dpwg-allele-function-phenotype-and-recommendation">C. DPWG Allele Function, Phenotype and Recommendation</h3>
<ol>
<li><p>PharmGKB annotates PGx-based drug dosing guidelines published by the <a href="https://www.pharmgkb.org/page/dpwg">Royal Dutch Association for the Advancement of
Pharmacy - Pharmacogenetics Working Group (DPWG)</a>. PharmGKB curates allele 
function assignments and phenotype mappings from the DPWG to provide genotype specific DPWG guideline
recommendations. Where possible, PharmGKB maps DPWG terms to CPIC terms, as outlined on
<a href="https://www.pharmgkb.org/page/dpwgMapping">PharmGKB</a>.</p></li>
<li><p>CYP3A4 is currently not part of a CPIC guideline. Since the DPWG CYP3A4 documentation includes limit variant
notations for the included alleles (only *16, *20, and *22 are specified) PharmCAT relies on
<a href="https://www.pharmvar.org/gene/CYP3A4">PharmVar CYP3A4 allele definitions</a>. However, the CYP3A4*16, *20 and *22
definitions are the same in both sources.</p></li>
<li><p>The CPIC UGT1A1 allele definition file includes *6, *27, *28, *36, *37, and *80. Since the DPWG UGT1A1 document
does not include allele definitions besides for the UGT1A1 TA box promoter polymorphism, PharmCAT only includes the
UGT1A1 positions from the CPIC UGT1A1 allele definition file. Other UGT1A1 alleles can be supplied as
<a href="https://pharmcat.org/examples/">outside calls</a> but not be determined from the VCF file by the Named Allele Matcher.</p></li>
<li><p>IMPORTANT: As of March 2022, gene information documents from the DPWG are no longer publicly available from the KNMP
website. PharmGKB is currently providing PDF versions of these documents to users. These files were downloaded in
February 2022. As such, it cannot be guaranteed that these documents match the mappings DPWG may use internally as
there have been no publicly accessible updates since February 2022.</p></li>
</ol>
<h3 id="d-pharmcat-exceptions-to-the-cpic-guideline-gene-list">D. PharmCAT Exceptions to the CPIC Guideline Gene List</h3>
<ol>
<li><p>PharmCAT does not determine CYP2D6, MT-RNR1, HLA-A, or HLA-B genotypes from the VCF file, but genotypes for CYP2D6,
MT-RNR1, HLA-A, or HLA-B can be provided to PharmCAT from an outside source and the corresponding phenotype 
prescribing recommendations will be included in the generated report. For the required format of the outside calls
refer to <a href="https://pharmcat.org">PharmCAT documentation</a>.</p></li>
<li><p>CPIC has assigned function to the following CYP2D6 CNV alleles: *1x2, *1x≥3, *2x2, *2x≥3, *3x2, *4x2, *4x≥3,
*6x2, *9x2, *10x2, *17x2, *29x2, *35x2, *36x2, *41x2, *41x3, *43x2, *45x2, *146x2. These alleles are part
of the CPIC diplotype to phenotype translation and can be connected to recommendations. Other CNV notations from
outside calls need to be mapped accordingly. </p></li>
</ol>
<h3 id="e-cpic-guideline-disclaimers-and-caveats">E. CPIC Guideline Disclaimers and Caveats</h3>
<ol>
<li><p>A version of the following quoted disclaimer is part of each CPIC guideline and applies to the CPIC recommendations
as used in PharmCAT. For the full description of potential benefits and risks, additional considerations (general and
specific to gene-drug pairs), limitations, information about respective gene nomenclature systems, potential
drug-drug interactions and clinical factors to consider, please see individual CPIC guidelines at
(<a href="https://cpicpgx.org">cpicpgx.org</a>).</p>
<ol>
<li><p>"CPIC guidelines reflect expert consensus based on clinical evidence and peer-reviewed literature available at
the time they are written and are intended only to assist clinicians in decision-making and to identify questions
for further research. New evidence may have emerged since the time a guideline was submitted for publication.
Guidelines are limited in scope and are not applicable to interventions or diseases not specifically identified.
Guidelines do not account for all individual variations among patients and cannot be considered inclusive of all
proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care
provider to determine the best course of treatment for a patient. Adherence to any guidelines is voluntary, with
the ultimate determination regarding its application to be made solely by the clinician and the patient. CPIC
assumes no responsibility for any injury to persons or damage to persons or property arising out of or related to
any use of CPIC's guidelines, or for any errors or omissions." (PMID:
<a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040">27997040</a>)</p></li>
<li><p>"Caveats: appropriate use and/or potential misuse of genetic tests. The application of genotype-based dosing is
most appropriate when initiating therapy with a tricyclic. Obtaining a pharmacogenetic test after months of drug
therapy may be less helpful in some instances, as the drug dose may have already been adjusted based on plasma
concentrations, response, or side effects. Similar to all diagnostic tests, genetic tests are one of several
pieces of clinical information that should be considered before initiating drug therapy." (PMID:
<a href="https://www.ncbi.nlm.nih.gov/pubmed/27997040">27997040</a>)</p></li></ol></li>
<li><p>CPIC guidelines reflect the alleles/genotypes known and considered by the guideline authors for inclusion by the time
of publication, however they may be updated online at
<a href="https://cpicpgx.org">cpicpgx.org</a> and in the CPIC database in between publications. Additional alleles and/or more
extensive allele definitions might exist by the representative gene nomenclatures for various genes.</p></li>
<li><p>CPIC is a registered service mark of the U.S. Department of Health &amp; Human Services (HHS).</p></li>
</ol>
<h3 id="f-pharmgkb-disclaimers-and-caveats">F. PharmGKB Disclaimers and Caveats</h3>
<p>PharmGKB is a registered service mark of the U.S. Department of Health &amp; Human Services (HHS).</p>
</section>


</main>
</body>
</html>
